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ABSTRACT 
 
 Future reproductive success of the dairy industry continues to decline as the push for high-
producing dairy cows increases. The transition from gestation into early lactation can be stressful 
for the dairy cow and result in low fertility in the future. Implementation of feed strategies can 
improve the transition from parturition to lactation for the cow, both metabolically and physically, 
and possibly reduce the risk of postpartum uterine diseases and early embryonic loss. Two 
experiments were conducted in order to observe the effects of nutritional supplementation on 
reproductive status and future embryonic development from the transition period to early lactation 
in Holstein cows.  
 To investigate the effect of rumen-protected methionine (RPM) on plasma amino acid 
concentrations, uterine cytology, immunohistochemistry (IHC) of glutathione peroxidase 1 
(GPX) and superoxide dismutase 1 (SOD), and to confirm neutrophil extracellular trap (NET) 
formation in the endometrial tissue, multiparous Holstein cows (n = 20) were randomly assigned 
to two treatments starting at 21 d before calving until 73 days in milk (DIM). Treatments were: 
CON (n = 9, no supplementation, TMR with a Lys:Met = 3.5:1) and MET (n = 11, TMR + 
Smartamine® M with a Lys:Met = 2.8:1). Endometrial biopsies, uterine cytology, and blood 
samples from the coccygeal artery or vein were collected at 15, 30, and 73 DIM. Blood plasma 
samples were analyzed for amino acids and metabolites. Uterine biopsies were analyzed for NET 
formation, neutrophil numbers, as well as GPX and SOD by IHC. Additionally, uterine cytology 
was analyzed for polymorphonuclear neutrophil (PMN) to epithelial cell proportion. Cows in 
CON had lower (P < 0.01) methionine plasma concentrations than cows in MET. Cows in CON 
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had greater (P < 0.01) cystine plasma concentrations than cows in MET. No treatment 
differences (P > 0.10) were observed for SOD or GPX in the endometrium. Cows in CON tended 
to have a higher score (P = 0.08) for positively immunolabeled GPX cells at 15 DIM than cows 
in MET. No treatment differences (P > 0.10) were observed for the proportion of PMN in uterine 
cytology, number of neutrophils, or extent of NET formation in the endometrium. A treatment by 
time interaction (P = 0.06) was observed for PMN proportion and the number of neutrophils: 
cows in MET tended to have greater PMN proportion than cows in CON at 15 DIM which 
decreased for subsequent days and cows in MET had greater neutrophil numbers in the 
endometrium at 30 DIM than cows in CON. In conclusion, dietary supplementation of RPM 
altered plasma amino acid concentrations and increased neutrophil infiltration in the postpartum 
period, suggesting improved uterine immunity.  
 Furthermore, we examined the effects of rumen-protected methionine on the lipid profiles 
of the preimplantation embryo and endometrial tissue. Multiparous Holstein cows (n = 20) were 
randomly assigned to two treatments starting at 21 d before calving until 73 days in milk (DIM). 
Treatments were: CON (n = 9, no supplementation, TMR with a Lys:Met = 3.5:1) and MET (n = 
11, TMR + Smartamine® M with a Lys:Met = 2.8:1). Endometrial biopsies were obtained at 15, 
30, and 73 DIM and preimplantation embryos were harvested at 73 DIM. Endometrial lipid 
profiles were analyzed using multiple reaction monitoring-profiling and lipid profiles of embryos 
were analyzed using matrix assisted laser desorption/ionization mass spectrometry. Cows in MET 
had increased (P ≤ 0.05) polyunsaturated lipid concentrations in embryos than cows in CON. Cows 
in MET had decreased (P < 0.10) monounsaturated lipid concentrations in embryos than cows in 
CON. Cows in CON had increased (P < 0.14) concentrations of saturated lipids in uterine tissue 
at 15 DIM than cows in MET. Cows in CON had increased (P < 0.13) concentrations of 
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un/monounsaturated lipids in uterine tissue at 15 DIM than cows in MET. Cows in MET had 
increased (P < 0.10) saturated lipid concentrations in uterine tissue at 30 DIM than cows in CON. 
Cows in MET had increased (P ≤ 0.05) concentrations of unsaturated lipids in uterine tissue at 30 
DIM than cows in CON. Cows in MET had increased (P ≤ 0.05) monounsaturated lipid 
concentrations in uterine tissue at 30 DIM than cows in CON. Concentrations of saturated lipids 
in uterine tissue at 73 DIM were increased (P = 0.06) for cows in MET than cows in CON. Cows 
in MET had increased (P = 0.10) concentrations of unsaturated lipids in uterine tissue at 73 DIM 
than cows in CON. Finally, cows in MET had increased (P ≤ 0.05) monounsaturated lipid 
concentrations in uterine tissue at 73 DIM than cows in CON. In conclusion, lipid profiles of the 
preimplantation embryo and endometrial tissue of cows fed RPM were altered, which may be 
indicative of improved embryonic vitality. The supplementation of RPM may improve 
reproductive success of dairy cows during and after the transition period, as well as reduce 
embryonic death in the future.  
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INTRODUCTION 
 
 Successful reproduction in dairy cattle is influenced by genetic interactions and 
environmental factors [1]. Dairy cattle have the ability to produce a replacement calf while 
enduring severe metabolic changes during parturition. Over the years, the dairy industry has shifted 
to favoring more productive cows while the fertility of those cows continues to decrease [2]. On 
average, todays Holstein cows produce over 10,000 kg of milk per lactation and about 35 kg of 
milk per day [3]. Overall, milk production in dairy cows from the United States has increased over 
10% in the last 10 years and shows no sign of decreasing [4]. The transition from gestation to 
lactation creates a challenge for dairy cattle through a marked increase in nutrient requirements as 
dry matter intake (DMI) decreases [5]. The down fall of the transition period is that cows cannot 
physically consume the required energy needed to begin lactation after calving, likely resulting in 
a negative energy state [6]. A recent review by Butler [7] describes how reproductive diseases and 
deficiencies, such as retained placenta, metritis, subclinical endometritis, and delayed conception 
are associated with NEB and can lead to decreased fertility. Implementation of feeding strategies 
to reduce any instances of NEB and improve fertility in dairy cows continues to be a challenge 
faced by the dairy industry.  
 Multiple studies have established the importance of implementing nutritional strategies to 
improve reproduction in dairy cows [8-10]. According to the NRC [11], methionine is considered 
one of the most limiting amino acids for dairy cows, followed by lysine. Addition of methionine 
to the diet of a dairy cow may improve DMI, ultimately reducing the risk of the cow entering a 
negative energy state [12].  In order to achieve a viable pregnancy and maintain fertility, the uterus 
endures chemical and morphological changes during the gestation period and after parturition [13]. 
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The uterus of the cow must provide an optimal environment for the preimplantation embryo in 
order for a pregnancy to become viable. Likewise, the pregnancy must be maintained while the 
mother provides balanced nutrition for proper fetal development. The link between balanced 
maternal nutrition and embryonic development is crucial during gestation [14]. Maternal 
nutritional deficiencies may lead to delayed metabolic development of the embryo, resulting in 
predisposed deficiencies due to disturbance of epigenetic mechanisms [14]. Moreover, 
development and synthesis of proteins in the fetus depends on a balance of non-dispensable and 
dispensable amino acids, suggesting the importance of nutrition in embryonic development [14]. 
The dairy industry depends on successful reproduction and improved fertility of the dairy cows for 
continued milk production since lactation is initiated by parturition. Therefore, implementation of 
nutritional strategies for the dairy cow are also crucial for the developing embryo and future dairy 
cow replacement population. 
 Implementing feed strategies to improve the transition from gestation to lactation will 
improve reproductive efficiency, leading to future milk production and maintenance of the dairy 
industry. Therefore, the objectives of my thesis are as follows: 
1. To determine the effects of rumen-protected methionine on uterine morphology and 
immune mediators as well as to observe formation of neutrophil extracellular traps 
(NET) in the bovine endometrium. 
2. To further understand the effects of rumen-protected methionine on the lipid profiles 
of the preimplantation embryo and endometrial tissue, which may be indicative of 
improved embryonic vitality.  
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CHAPTER 1 
LITERATURE REVIEW 
 
TRANSITION PERIOD 
 The transition from gestation to lactation is classically defined as 3 weeks before calving 
until 3 weeks after parturition [5].  It is during this time to which majority of metabolic disorders 
occur [15]. The dairy cow endures a sequence of events from preparing to give birth and expelling 
the fetus with significant hormonal changes to having a rapid increase in nutritional requirements 
as the mammary gland begins to lactate. These extreme changes deliver a substantial degree of 
stress to the dairy cow that can affect milk production and reproductive success. As stated by 
Drackley [5] “the success of the transition period effectively determines the profitability of the 
cow during the lactation”. While many articles have been published on the topic, the transition 
period continues to be a challenge for the dairy industry through impacting reproductive efficiency 
[5-10].  
 Negative energy balance is the result when feed intake is reduced and nutrient requirements 
increase during the transition period [16]. The energy requirements of production for a dairy cow 
that produces 35 kg of milk daily are three times greater than the energy required for maintenance 
[17]. The dairy cow is physically and metabolically unable to consume enough feed to meet the 
dramatic increase in energy requirements for lactation [6]. As a result, negative energy balance 
(NEB) can have detrimental effects on the health of the mother and development of future fetuses. 
Nonesterified fatty acids (NEFA) are mobilized from adipose tissue to the liver in response to low 
energy in the body, where oxidation can take place to create triglycerides for export [5]. However, 
the rapid influx of nonesterified fatty acids to the liver and decreased secretion of triglyceride to 
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very low-density lipoproteins leads to accumulation of triglyceride in the liver, also known as fatty 
liver [18]. Similarly, b-hydroxybutyrate (BHB), a major component of ketone bodies, reflects the 
livers capacity to oxidize fats. While the concentrations of NEFA increases and overwhelms the 
liver, BHB is created along with ketone bodies due to incomplete oxidation of fatty acids into 
acetyl Coenzyme A.  As a result, the BHB and ketone bodies are secreted into the blood stream, 
resulting in ketosis. Briefly, clinical ketosis is characterized by weight loss, refusal of feed, and 
decreased milk production. Occasionally, clinically ketotic cows may be depressed with a “staring 
expression” and experience nervous impulses such as excessive chewing or salivating [19]. 
Diagnosis of clinical ketosis is made on the basis of observed symptoms, as described above, and 
through measuring BHB, also called ketone bodies, in the blood serum. Dairy cows experiencing 
clinical ketosis in early lactations typically have a blood serum BHB concentration above 2600 
μmol/L. On the other hand, subclinical ketosis is not accompanied by clinical signs. Subclinical 
ketosis is solely diagnosed by the concentration of BHB, which is typically above 1000 μmol/L 
for lactating dairy cows [20]. While the ketones are able to be utilized by muscle, they provided 
little energy as compared to fatty acid oxidation [21]. Concentrations of NEFA and BHB can be 
measured in order to monitor NEB and have been shown to be associated with displaced 
abomasum and decreased reproductive performance at elevated levels [21]. While it is important 
to monitor the dairy cow through the transition period to reduce the severity of NEB, the primary 
focus should be to implement feeding strategies to prevent NEB from occurring, therefore, making 
the transition from calving to lactation a less stressful process for the cow. 
 Leblanc [21] describes how almost all dairy cows experience one of the following events 
during the peripaturient period: insulin resistance, reduced feed intake, NEB, lipolysis, weight loss, 
hypocalcemia, and reduced immune function that may lead to increased bacterial infection in the 
  
5 
 
uterus. According to Sheldon et al. [22], the development of uterine diseases depends on the 
immunological capacity of the cow, the bacterial species present, and the concentration of bacteria 
in the bovine uterus. Since negative energy balance is an immunosuppressive event, uterine disease 
is expected during the transition period when the cow is in a negative energy state [23]. Negative 
energy balance, can be prevented through understanding the metabolic capacity of the dairy cow 
through improving management and intervening with nutritional supplementation.  
 
NUTRITION AND REPRODUCTION 
 While NEB can affect the metabolic status of the dairy cow, association of NEB with 
reproductive diseases and deficiencies, such as retained placenta, metritis, and delayed conception 
has been described as leading to decreased fertility [7]. Butler and Smith et al. [17] described that 
NEB is directly related to delayed ovarian activity and lower conception rates, possibly through 
decreased luteinizing hormone pulsing or ovarian responsiveness to hormones. Increased 
concentrations of NEFA (≥ 0.6 mmol/L) are common during NEB and are a risk factor for metritis 
in the postpartum period [24]. Similarly, decreased feeding time and DMI in the peripaturient 
period are indicators of metritis [25]. Between -7 and -2 days before calving, cows that were 
diagnosed as mildly metritic or severely metritic decreased their feed intake by 0.21 and 0.33 kg/d 
respectively as compared to healthy cows that experienced a feed intake decrease of 0.15 kg/d. 
Not surprisingly, cows that were diagnosed with severe metritis had continued to decrease feed 
intake by 34% one day after calving as compared to mildly metritic (13%) or healthy (11%) cows. 
As a result, the cows diagnosed with metritis continued to have decreased milk production for that 
lactation [25].  As previously stated, NEB is an immunosuppressive event that can impair 
reproductive immune functions. Hammon et al. [26] discovered that neutrophil killing activity was 
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greatly reduced during the peripaturient period from cows that were previously diagnosed with 
metritis. Additionally, cows that were diagnosed with subclinical endometritis and puerperal 
metritis or subclinical metritis alone had significantly higher NEFA and BHB concentrations along 
with decreased DMI. A negative energy state mainly affects the immune function of the dairy cow, 
leading to decreased reproductive success. However, the future impact of NEB on the developing 
embryo is commonly overlooked.  
 The balance between maternal nutrition and embryonic development is crucial for embryo 
survival and pregnancy maintenance. While the energy status of the cow may be stable at the 
moment of embryo implantation and development, previous NEB with secondary infections in the 
uterus may negatively affect the survival of the embryo. A steady decline in reproductive success 
in dairy cattle has been seen over the years, with high rates of embryonic loss occurring around 17 
days after insemination and slowly decreasing as the days of gestation increase [2]. Cows that have 
shown evidence of postpartum uterine disease have increased lymphocytic foci (containing B and 
T-cells) and fibrosis, also known as scaring, in the uterine endometrium that may lead to early 
embryonic death [27]. Vanholder et al. [28] further demonstrated how NEFA inhibits the growth 
and survival of granulosa cells that were cultured in various media containing saturated fatty acids. 
Addition of palmitic acid and stearic acid, symbolizing NEFA, resulted in inhibited granulosa cell 
proliferation at a concentration of 150, 300, or 500 μM. Oleic acid had the greatest inhibitory effect 
on granulosa cell proliferation at a concentration of 500 μM. It is hypothesized that these particular 
NEFAs resulted in decreased cell proliferation through inducing apoptosis [28]. Therefore, 
reducing the risk of uterine disease, caused by NEB, is mandated in order to reduce embryonic 
loss and improve reproductive success.  
  
7 
 
In addition to NEB affecting the uterine environment, other maternal nutritional 
deficiencies may reduce the ability of the dairy cow to maintain a pregnancy. The establishment 
of a viable pregnancy begins when the embryo sends a signal, interferon-t, to the uterus in order 
to inhibit secretion of prostaglandin F2α [29]. Interruptions in the signal between the uterus and 
embryo, which may be a result of nutritional deficiencies, could lead to decreased fertility. 
DelCurto et al. [14] describes how maternal nutritional deficiencies may delay embryo 
development, ultimately impacting future epigenetic mechanisms. Progesterone is the hormone 
responsible for maintaining pregnancy in addition to aiding in interferon-t production and embryo 
development [30]. Even though NEB occurs during the transition period, the effects impact future 
ovarian cycles, leading to significantly lower progesterone levels [31].  
Dairy cattle require dietary supplementation of methionine due to their inability to 
synthesize the amino acid [11]. The methionine requirement for dairy cattle is about 2.12% of the 
total metabolizable protein provided and should remain at an optimal ratio of 3:1 of Lys:Met [11-
12]. Inclusion of various amino acids, especially indispensable amino acids, has become 
increasingly popular in the dairy industry.  Methionine is most beneficial when fed in its rumen-
protected form due to rapid degradation in the rumen. Studies have shown that supplementation of 
rumen-protected methionine resulted in increased methionine ruminal bypass, small intestine 
degradation, and plasma methionine concentrations as compared to unprotected methionine [32-
33]. Methionine is a sulfur containing amino acid that plays a role in many physiological processes. 
For example, methionine can be converted into S-adenosylmethionine and further provide methyl 
groups to DNA [34].  Moreover, S-adenosylmethionine is a methyl donor for the methylation of 
phospholipids into phosphatidylcholine, which are valuable lipids for membrane integrity [35-36]. 
Beyond methyl donation, methionine can be metabolized into homocysteine, cystathionine, and 
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finally cysteine, which is a source for the antioxidant glutathione [37-38]. Dietary supplementation 
of methionine has many health benefits for dairy cows. Zhou et al. [12] observed reduced instances 
of clinical ketosis and retained placenta as well as increased DMI intake. The notable increase in 
DMI may reduce the risk of NEB during the transition period. Similarly, blood polymorphonuclear 
leukocyte phagocytosis capacity and oxidative burst activity were increased for cows that were 
supplemented with methionine [38].  
According to Bazer et al. [39], amino acids are a valuable nutrient required during the 
preimplantation period. One way that the uterus communicates with the fetus is through nutrient 
and amino acid transport via histotroph. Since histotroph is mainly composed of methionine, the 
developmental capacity of the embryo may be increased when there is maternal supplementation 
of methionine [39]. Toledo et al. [40] observed a decrease in pregnancy loss for cows 
supplemented with methionine. Similarly, a notable increase in embryonic size was observed in 
multiparous cows that had been supplemented with methionine [40]. However, reductions in B 
vitamins and methionine have resulted in altered epigenetics and DNA methylation of offspring, 
leading to modified adult health-related phenotypes in sheep [41]. Amino acids are important for 
many physiological and metabolic processes. Supplementation of methionine may improve the 
transition from gestation to lactation, reduce postpartal uterine diseases, as well as increase the 
developmental and survival capacity of future embryos.  
 
UTERINE HEALTH 
 The goal of reproductive management is to have cows become pregnant at an optimal time 
interval after calving that is biologically and economically profitable [22]. The typical voluntary 
waiting period to breed a cow is between 50 to 60 days after calving [42]. As previously described, 
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factors that determine the risk of uterine diseases in dairy cows depend mainly on the 
immunological capacity and the bacteria present. However, when the body is metabolically 
stressed during parturition, the immune system can no longer function properly, leading to 
postpartum uterine infections. In order for a diagnosis to be made, proper definition of the disorder 
must be established. For clarification purposes, the definitions of metritis and endometritis in 
addition to diagnostic techniques will be described. 
 Metritis affects anywhere from 8 to 40% of high producing dairy cows with the average 
hovering around 20%. Galvao [43] reports that while metritis can occur anytime within the first 
21 days after calving, majority of the cases (95%) are diagnosed around 14 days in milk (DIM). 
Metritis is characterized as the infection and inflammation of the uterus within the first 21 days 
after calving [22]. Clinical signs, such as red-brown discharge with a fetid smell and an enlarged 
uterus accompanied with other signs of systemic illness (fever > 39.5 ºC) are commonly associated 
with puerperal metritis [22, 43]. Clinical metritis has similar diagnostic characteristics to puerperal 
metritis, however, systemic signs are absent and purulent discharge is easily identified [43]. 
Diagnostic methods that are effective and efficient at detecting metritis in the postpartum dairy 
cow are the gloved hand and a vaginal device called the metricheck® device. The diagnostic 
technique is similar for both methods: the gloved hand or metricheck® device are inserted through 
the vaginal cavity until the cervix is reached. From there, each is retracted and the adhered vaginal 
discharge can be evaluated [44]. The vaginal discharge can be evaluated for smell and overall 
appearance or pus content. A smell score of 0 = no smell and a smell score of 3 = fetid odor, 
signifying the presence of bacteria. The overall visual score of the discharge ranges from 0 to 3: 
score 0 = clear mucus, score 1 = clear mucus with flecks of white pus, score 2 = mucus with ≤ 
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50% purulent material, and score 3 = bloody or ≥ 50% purulent material [22]. The metricheck® 
device is an efficient and low-cost way to diagnose cows with metritis soon after calving.  
 Clinical endometritis is characterized by the presence of muco-purulent discharge 21 days 
after calving without systemic signs. Subclinical endometritis is the most prevalent of the uterine 
diseases affecting over 30% of lactating dairy cows with a range from 11 to 70% in some herds 
[43]. Clinical endometritis can reduce pregnancy rates by 27% and result in cows that are 70% 
more likely to be culled due to reproductive failure [45]. Subclinical endometritis is characterized 
by the absence of muco-purulent discharge 21 days after calving. One method for diagnosing 
subclinical endometritis is through cytology of the uterine lining. A stainless-steel cytology rod is 
inserted into the uterine body via rectal palpation and manipulation of the cervix. The cytology 
brush is exposed and rotated while remaining in contact with the uterine lining. The cytological 
findings are evaluated based on the proportion of polymorphonuclear neutrophils (PMN) to 
epithelial cell count. Cows are considered to have subclinical endometritis if there are > 18% PMN 
cells present at 30 DIM or > 5% PMN cells at 73 DIM [22, 46]. Uterine flushing has also been 
utilized to diagnose endometritis either based on the bacteria present, number of neutrophils in the 
sample, or optical density of the fluid harvested. The procedure consists of inserting a catheter into 
the uterine body, similar to the cytology procedure, flushing saline into the uterine body and 
aspirating the fluid [47]. Increased values for optical density and neutrophil number are associated 
with endometritis. Cows that were diagnosed via uterine flushing were 25% less likely to become 
pregnant after the first service, leading to increased days open. Moreover, cows diagnosed with 
endometritis took between 30 to 88 days longer to conceive [48]. On average, treatment for uterine 
diseases in dairy cows cost $52.60 per cow and over $473 million yearly [49].  Preventing uterine 
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disease in dairy cattle can improve reproductive efficiency while reducing economic burdens of 
the farmer.  
 The uterus endures chemical and morphological changes during the preimplantation period 
through parturition in order to support a viable pregnancy and prepare for future conception [50]. 
The physiological process of uterine involution and preparation for conception can take from 6 to 
8 weeks after calving [51]. Adenogenesis is the process by which endometrial glands begin to 
develop, resulting in extensive branching throughout the stroma and myometrium of the uterine 
lining [50]. Development of endometrial glands are vital for embryo survival because they secrete 
and transport nutrients, such as histotroph, that aid in embryonic development. The endometrial 
glands of ruminants are possible sites of implantation for the embryo [52]. The use of endometrial 
biopsies to evaluated fertility began in the early 1960’s [53]. Today, endometrial biopsies can 
provide a deeper understanding of ruminant fertility on a cellular level. Chapwanya et al. [53] 
describes the detailed process of harvesting the endometrial tissue. Evaluation of uterine biopsies 
from dairy cows with infected uteri revealed an increase in lymphocytic foci (containing B and T-
cells), fibrosis, and necrosis, possibly leading to embryonic loss and decreased fertility [51, 54]. 
The discovery of endometrial tissue sampling provides histological and molecular insight as to 
why a cow may have reduced reproductive success after uterine infections.  
 Neutrophils are an important leukocyte that quickly invade the area of infection or tissue 
damage. The ability for neutrophils to eliminate pathogens through phagocytosis, oxidative burst, 
and secretion of antimicrobial peptides is well established.  Recently, however, a new mechanism 
of pathogen elimination, termed neutrophil extracellular trap (NET) formation, has been 
discovered. Neutrophil extracellular trap formation begins with activation of the neutrophil via IL-
8, lipopolysaccharide, or bacteria/fungi [55]. Once activated, the nuclear membrane begins to 
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disintegrate, resulting in the loss of its lobular shape, and filling of the entire cellular space with a 
mixture of nuclear and granular material. Finally, the integrity of the cell membrane is lost and the 
neutrophil burst, expelling its intracellular content into the surrounding environment [55]. The 
expelled nuclear material is studded with histones and antimicrobial agents, such as 
myeloperoxidase and neutrophil elastase, which can destroy pathogens [56]. Neutrophil 
extracellular trap formation has been studied in human blood challenged with A. fumigatus, 
endometrial mucus from mares diagnosed with endometritis that contained common bacteria for 
the disorder, and bovine blood that was challenged with E. coli [57-59]. Unfortunately, the extent 
of research regarding NET formation in tissue is limited, but may provide valuable insight to the 
immune function of various tissues. While neutrophils are important for pathogen elimination, 
they have been traditionally used as indicators of infection. For instance, an increase in neutrophil 
number after parturition is an indicator of metritis or endometritis. However, in a cow that has 
nutritional assistance via dietary supplementation, the increase in neutrophil infiltration right after 
calving could symbolized a robust immune response that can resolve uterine infections more 
effectively. Dairy cows supplemented with rumen-protected methionine had increased blood 
neutrophil phagocytosis, suggesting improved immune function [38, 60]. LeBlanc [61] 
hypothesized that increased neutrophil infiltration after calving may be an indicator of improved 
immune response.  
 
THE DEVELOPING EMBRYO 
 Future herd expansion and milk production in the dairy industry relies on viable 
pregnancies to initiate lactation and produce replacement heifers that subsequently reproduce 
efficiently. Unfortunately, embryo quality, survival, and development continue to be compromised 
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in high producing dairy cows [31]. The preimplantation period is the most vital time for an embryo 
in order to create a viable pregnancy. In most mammals, 20 to 40% of embryonic death occurs 
during the preimplantation period [39]. Initiation of a new pregnancy begins when the dominant 
follicle ovulates, resulting in the release of an oocyte which can then be fertilized by sperm. The 
decapitated spermatozoa bind to the zona pellucida of the oocyte, activating a cascade of events. 
Once bound, an acrosomal reaction occurs that allows the spermatozoa to penetrate the zona 
pellucida and alters the membrane integrity of the spermatozoa so that it can fuse to the plasma 
membrane of the oocyte. At this time, cortical granules move to the periphery of the oocyte 
cytoplasm, forming a zona block that cannot be penetrated by other sperm. The spermatozoa is 
engulfed by the micro villi present on the plasma membrane of the oocyte and the nuclear 
membrane of the spermatozoa disintegrates, revealing the nuclear material which is known as the 
pronuclei. The final stage of fertilization occurs when the pronuclei of the female and male fuse, 
called syngamy [62].  
Four stages must be achieved before the embryo can be implanted to the uterus: 1. develop 
within the zona pellucida, 2. hatching of the blastocyst from the zona pellucida, 3. maternal 
recognition of pregnancy, and 4. formation of extraembryonic membranes. At this stage, the 
embryo is called a zygote, symbolizing that the pronuclei from the male and female have been 
fused. The zygote undergoes a series of cleavage divisions until it reaches the morula stage when 
the individual blastomeres can no longer be counted due to the extensive number of cells. 
Overtime, water begins to diffuse through the zona pellucida, forming a fluid filled cavity known 
as a blastocoele. The blastocyst continues to increase in size, eventually leading to the rupturing 
of the zona pellucida [62]. The implantation continues after the shedding of the zona pellucida, 
resulting in elongation and exposure of the trophoblast, followed by orientation and attachment of 
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the blastocyst to the endometrium via trophectoderm adhesions [52]. During this phase, around 14 
days after breeding, the blastocyst can be easily removed from the uterus via lavage. The elongated 
blastocyst undergoes a process known as apposition where it further steadies the adhesions to the 
endometrial lumen epithelium. In many ruminants, the uterine glands are also an area of apposition 
for the early blastocyst [63]. After implantation, the trophoblastic cells create further adhesions 
which have been hypothesized to play an important role in histotroph absorption [63]. Adhesion 
of the trophoblast to the endometrial lumen epithelial cells requires a series of molecules, 
specifically glycosylated cell adhesion molecule 1, galectins, and osteopontin [52]. These 
molecules also provide signaling between the uterine lining and developing embryo. It is the final 
stage of adhesion when the embryo is the most stable, however, attempted removed of the embryo 
via lavage will result in structural damage. The embryo phase of development ends when the fetal 
membranes begin to attach to the uterine lining, to which the fetal period begins and the embryo 
is called a fetus [64].  During the fetal period, the fetus continue to develop as fetal weight increase 
by 10 g per day in many dairy breeds [64].  
 The development of the embryo relies on adequate nutrition from the mother. Maternal 
nutritional deficiencies may lead to disturbances if epigenetic mechanisms in developing embryos 
[14]. Both the mother and developing embryo require methionine. Preimplantation embryos 
require between 14 and 21 μM/L of methionine [65]. Methionine may have beneficial effects on 
the lactating dairy cow and developing embryo, as previously stated. Takahishi et al. [66] stresses 
the importance of supplying required nutrients to the developing embryo. Glucose, lactate, 
pyruvate, and amino acids are only of few that have been found to increase embryo development 
while also having detrimental effects if limited [66]. Early embryonic death may occur if a suitable 
environment and balanced nutrition are withheld. According to De Vries [67], the cost of 
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pregnancy for an individual cow is based on the difference of future cash flow when she is pregnant 
versus when she is not pregnant, considering some variation due to different milk yields for each 
cow. On average, pregnancy loss in dairy cows is about $555 per cow which increases as gestation 
length increases [67]. Similarly, initiating a new pregnancy through breeding protocols can cost 
upwards of $250 and continues to increase as the efficiency of estrus detection decreases [67]. 
Therefore, reducing embryonic loss can help increase the economic efficiency of the dairy farm. 
  
LIPID PROFILES OF THE EMBRYO AND ENDOMETRIUM 
 Lipids are composed of fatty acids that fulfill majority of the energy requirements of the 
bovine reproductive tract and developing embryo during pregnancy [68]. Triacylglycerides are 
commonly found in the cell cytoplasm and provide a substantial amount of energy to embryos 
[69]. Likewise, phosphatidylcholine and sphingolipids are important for cell membrane integrity 
[70]. Similarly, ceramides, which are part of the sphingolipids class, regulate a number of cellular 
processes through signaling, such as apoptosis, cell differentiation, and activation of protein kinase 
C [71]. Fatty acid reserves in cattle, sheep, and pig oocytes contained at least 50% of palmitic and 
oleic acid with triglycerides being the most fatty-acid rich fraction [72]. Lipid content and usage, 
specifically triacylglycerides with an observed concentration of 62 ± 1.14 ng, in bovine oocytes 
has been previously established during the preimplantation stages [73-74]. A previous study 
revealed that the addition of amino acids in media resulted in increased number of cells in the 
blastocyst, suggesting improved development [66]. Methionine can alter lipid profiles through 
synthesis of S-adenosylmethionine (SAM), S-adencylhomocysteine (SAH), phosphocholine, 
CDP-choline, and finally the production of phosphatidylcholine (Figure 1.1). Phosphatidylcholine 
then aids in the synthesis of very low density lipoproteins, which aid in triacylglycerol removal 
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from the liver. Acosta et al. [75] observed an increase in lipid accumulation in preimplantation 
embryos from cows supplemented with rumen-protected methionine. Therefore, supplementation 
of methionine may lead to improved embryonic development and survival through lipid 
accumulation and amino acid utilization. Similar hypothesis regarding how changes in maternal 
nutrition affect lipid composition in early developing bovine embryos have been established [76]. 
Addition of a lipid-rich diet to the mother resulted in a reduction of the number of oocytes that 
were able to develop into the blastocyst stage by a factor of 0.52 [76]. However, the extent of 
which lipids negatively affect the embryonic development is unknown.  
 Identifying the presence of lipids in embryos has led to amplified interest of the specific 
lipid types that accumulate within the embryo. Lipid profiling provides valuable information 
regarding the quantification and identification of specific lipid markers present in a sample. The 
development of matrix assisted laser desorption/ionization (MALDI) mass spectrometry allows 
for analysis of loosely bonded molecules, such as those in embryos as compared to traditional mass 
spectrometry [77]. Some added benefits of MALDI are that there is no need for extraction, 
chemical manipulation, or the need for pre-separation of samples [78]. Lipid profiling of embryos 
with MALDI begins with the administration of a single embryo on a 384 well plate. A matrix can 
be applied to the plate in order to protect the sample. From there, the embryos on the plate are 
ionized and a pulse is applied, resulting in the release of the ion. The time to which the ion remains 
in the air, also known as time of flight, reveals information regarding the mass of the molecule. 
For example, if a molecule is heavy, that molecule will have a shorter time of flight.  This 
information is collected and correlated with lipid databases to discover the specific lipid markers 
that are most prominent in the samples. Multiple studies have been completed regarding lipid 
profiling through the use of MALDI [79-82].  
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Unlike traditional lipid profiling through mass spectrometry, the discovery of multiple 
reaction monitoring-profiling (MRM) allows for molecular specificity through precursor and 
neutral loss scans while providing valuable information regarding the identity of lipid markers 
[83]. Multiple reaction monitoring mass spectrometry is an efficient way to quickly narrow down 
possible lipid markers that are present in samples through a discovery phase and screening phase. 
The lipids must be extracted from the sample before being run through a triple quadruple machine. 
Selection of the parent ion, fragmentation, and monitoring occurred at each individual quadrupole, 
respectively. The discovery phase consists of reducing the number of possible lipids present in the 
sample while the screening phase allows for efficiency while monitoring the lipid markers that 
were found during the discovery phase.  Similar to the MALDI outcome, MRM presents valuable 
information regarding the identification and quantification of specific lipid markers. The MRM 
can be used for tissue or fluid samples due to the homogenization step before analysis. This method 
of lipid profiling may reveal the identity of specific lipids in the uterus, resulting in further 
understanding of the interaction between the uterus and developing embryo.  
Limited research has been conducted in regards to the lipid profiling of the uterus. One 
previous study observed increased lipids in the luminal epithelium of the progesterone dominant 
rat uterus via electron microscope. However, the extent of understanding as to which specific lipids 
were present still remains a mystery. Gene expression of bovine endometrial tissue can also 
provide links to the importance of lipids during pregnancy. Wathes et al. [84] describes that 
PLA2G10, a gene responsible for lipid accumulation and lipoprotein modification, is greatly down 
regulated in cows that experience NEB. This study further supports the need for nutritional 
intervention in order to make the transition from gestation to lactation smoother and improve 
embryo vitality.  
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CONCLUSIONS 
 The transition from parturition to lactation continues to be a challenge in the dairy industry. 
The transition period emanates a substantial degree of stress of the dairy cow, both metabolically 
and physically. Increased requirements in energy coupled with decreased feed intake result in 
NEB, leaving the cow at risk for metabolic and reproductive disorders. Subsequently, those cows 
may have reduced reproductive success in the future. Negative energy balance continues to affect 
the cows in their future lactations through decreased milk production and increased risk for 
embryonic loss. The interaction between maternal nutrition and embryonic development is a 
delicate set of steps that, when altered, may result in early embryonic loss. Since methionine is a 
limiting amino acid in dairy cows and embryos, dietary supplementation of the indispensable 
amino acid may benefit the cow during the transition period as well as lead to improved 
reproductive success and reduced embryonic loss. Furthermore, understanding the lipids present 
in the uterus and embryo may provide insight as to how these two components interact and can be 
affected by nutrition. Finally, to the best of our knowledge, observation of NET formation in the 
bovine endometrial tissue for the first time may lead to further research regarding the immune 
function in the uterus of dairy cows. Nutritional intervention may reduce metabolic stresses during 
the transition period and in turn lead to improved embryonic vitality, ultimately affecting the dairy 
industry in a positive way.
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FIGURES  
 
 
Figure 1.1.  Methionine metabolism pathway showing the link between methionine breakdown 
into  S-adenosylmethionine (SAM), S-adenocylhomocysteine (SAH), phosphocholine, CDP-
choline, and finally resulting in the production of phosphatidylcholine (PC) that can be converted 
into very low density lipoproteins (VLDL) that aid in triacylglycerol (TG) transport.
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CHAPTER 2 
IMPROVED UTERINE IMMUNE MEDIATORS IN HOLSTEIN COWS 
SUPPLEMENTED WITH RUMEN-PROTECTED METHIONINE AND OBSERVED 
NEUTROPHIL EXTRACELLULAR TRAP (NET) FORMATION IN BOVINE 
ENDOMETRIAL TISSUE  
 
ABSTRACT 
During the transition from prepartum to early lactation, dairy cows often experience 
negative energy balance (NEB) that may result in reproductive stress and decreased fertility. The 
objective of this study was to observe the effects of rumen-protected methionine (RPM) on plasma 
amino acid concentrations, uterine cytology, immunohistochemistry (IHC) of glutathione 
peroxidase 1 (GPX) and superoxide dismutase 1 (SOD), and to confirm neutrophil extracellular 
trap (NET) formation. Multiparous Holstein cows (n = 20) were randomly assigned to two 
treatments starting at 21 d before calving until 73 days in milk (DIM). Treatments were: CON (n 
= 9, no supplementation, TMR with a Lys:Met = 3.5:1) and MET (n = 11, TMR + Smartamine® 
M with a Lys:Met = 2.8:1). Uterine endometrial biopsies, uterine cytology, and blood samples 
from the coccygeal artery or vein were collected at 15, 30, and 73 DIM. Blood plasma samples 
were analyzed for amino acids and metabolites. Uterine biopsies were analyzed for NET 
formation, neutrophil numbers, as well as GPX and SOD by IHC. Additionally, uterine cytology 
was analyzed for polymorphonuclear neutrophil (PMN) to epithelial cell proportion. Cows in CON 
had lower methionine plasma concentrations (18.05 ± 2.0 μM) than cows in MET (30.39 ± 1.6 
μM). Cows in CON had greater cystine plasma concentrations (3.62 ± 0.3 μM) than cows in MET 
(2.8 ± 0.3 μM). No treatment differences were observed for SOD or GPX in the endometrium. 
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Cows in CON tended to have a high score for positively immunolabeled GPX cells at 15 DIM than 
cows in MET. No treatment differences were observed for the percentage of PMN in uterine 
cytology, number of neutrophils, or extent of NET formation in the endometrium. A treatment by 
time interaction was observed for PMN percentage and the number of neutrophils: cows in MET 
tended to have greater PMN percentages than cows in CON at 15 DIM which decreased for 
subsequent days and cows in MET had greater neutrophil numbers in the endometrium at 30 DIM 
than cows in CON. In conclusion, dietary supplementation of RPM altered plasma amino acid 
concentrations and increased neutrophil infiltration in the postpartum period, suggesting improved 
uterine immunity.  
 
Key words: Methionine; neutrophil extracellular trap; polymorphonuclear neutrophils; 
immunohistochemistry. 
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INTRODUCTION 
The increase in nutritional requirements and decreased dry matter intake (DMI) during the 
transition period results in metabolic and reproductive challenges that can affect the productivity 
of the cow’s future lactation [1]. Implementation of nutritional strategies during the transition from 
low energy requirements in the dry period to high energy requirements in the lactation period may 
reduce the metabolic stress of the transition period. A recent review by Butler [2] describes how 
reproductive diseases and deficiencies, such as retained placenta, metritis, subclinical 
endometritis, and delayed conception are associated with negative energy balance (NEB) and can 
lead to decreased fertility. Understanding the changing metabolic requirements of the dairy cow 
and implementing feeding strategies during the transition period to prevent the nutritional 
deficiencies that lead to NEB can improve reproductive performance and uterine recovery of the 
dairy cow after parturition [3]. 
Methionine is one of the most limiting amino acids for dairy cattle [4]. Rapid degradation 
of this amino acid in the rumen can result in low absorbance in the small intestine and decreased 
availability [5]. Previous studies have shown that supplementation of rumen-protected methionine 
(RPM) increased methionine ruminal bypass, small intestine degradation, and plasma methionine 
concentrations [5, 6]. Additionally, supplementation of RPM leads to increased DMI during the 
transition period, greater plasma concentrations of sulfur-containing compounds (cystathionine, 
cystine, homocystine, and taurine), and availability of amino acids (lysine, arginine, tryptophan, 
threonine, proline, asparagine, alanine, and citrulline) that were once limited as a result of NEB 
[7, 8]. 
 Negative energy balance during the peripaturient period is immunosuppressive [9]. 
According to Sheldon et al. [10], the development of uterine diseases depends on the 
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immunological capacity of the cow, the bacterial species present, and the concentration of bacteria 
in the bovine uterus. Therefore, uterine disease is expected when NEB balance and contamination 
of the uterus are present. In healthy animals, neutrophils, a type of leukocyte, are constitutively 
present in the reproductive tract. In response to infection, these cells rapidly infiltrate affected 
tissues and are essential in clearing pathogens as well as dead tissue [11]. Interestingly, an inhibited 
immune response can result in persistence of the infection and delayed conception as modeled by 
LeBlanc [11]. Studies have shown that supplementation of RPM can improve the immune status 
of the cow and increase blood neutrophil function via phagocytosis and oxidative burst activity 
[12, 13]. Increased polymorphonuclear neutrophils (PMN) in the uterus can be an indicator of 
endometritis [10, 14]. However, an increase in neutrophil infiltration during the first two weeks 
after parturition may be an indicator of improved immune function as hypothesized by LeBlanc 
[11].   
 In order to achieve a viable pregnancy and maintain fertility, the uterus endures chemical 
and morphological changes during the gestation period and after parturition [15]. Development of 
endometrial glands, termed adenogenesis, consist of the growth of glands that result in secretion 
of histotroph and other substances that aid in fetal growth and uterine recovery after birth [15]. 
However, malfunction of the uterus or under development of the specific glands, may lead to 
decreased fertility in the future [16]. Nutritional deficiencies can also lead to impaired uterine 
function, due to persistent infection and reduced immune defenses, which may impact reproductive 
efficiency [11]. Chronic inflammation, including increased lymphocytic foci (containing B and T-
cells), may result in embryonic losses from cows that previously had postpartum uterine diseases 
[17]. Histotroph secretions are mainly composed of serine and methionine, therefore, 
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supplementation of methionine may increase amino acid availability for histotroph secretion and 
lead to better fetal development [18].  
Presence of antioxidant factors, such as Glutathione Peroxidase 1 (GPX) and Superoxide 
Dismutase 1 (SOD), may decrease damaging reactive oxygen species and impact uterine 
physiology [11, 19]. Results from a previous study reported that GPX and SOD are commonly 
expressed in the canine endometrium during the estrus cycle and in different epithelial structures, 
suggesting that these factors play an important role in the cycling uterus [19]. Likewise, gene 
expression of GPX and SOD are commonly found in the bovine oviduct, with an up-regulation of 
GPX genes occurring before ovulation, suggesting that these antioxidants may play a role in 
successful fertilization and implantation [20].  
 Therefore, the objectives of this study were to determine the effect of feeding RPM on 
neutrophil infiltration, uterine morphology, and expression of GPX and SOD, as well as to confirm 
neutrophil extracellular trap (NET) formation in the endometrium of Holstein cows during the 
postpartum period.  
 
MATERIALS AND METHODS 
Experimental design and dietary treatments 
The following procedures were approved by the University of Illinois (Urbana-
Champaign) Institutional Animal Care and Use Committee (IACUC). A total of 20 Holstein cows 
entering their second or greater lactation (parity 3.0 ± 1.2) were included in the experiment from 
21 days before calving until 73 days in milk (DIM). Cows were housed in free stalls with individual 
Calan feed gates (American Calan Inc., Northwood, NH, USA) during the prepartum period and 
moved to individual maternity pens within the same barn approximately 2 days before their 
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expected calving date.  After parturition, all cows were housed in tie stall barns at the University 
of Illinois Urbana-Champaign Research Dairy Farm and milked three times a day. 
All cows received a complete total mixed ration (TMR) diet that met the energy 
requirements of the cows according to the NRC 2001 [4] as previously stated in Acosta et al. [21]. 
Twenty-one days before calving, cows were randomly assigned to one of two treatments, which 
were given as a top-dress on the TMR: 1) no supplementation; (CON; n = 9; Lys:Met = 3.5:1) or 
2) supplementation with RPM; [MET; n = 11; RPM at a rate 0.08% of DM: Lys:Met = 2.8:1, 
(Smartamine ® M Adisseo, Alpharetta, GA, USA)]. The dosage of RPM was established based on 
Zhou et al. [7].  
 
Synchronization protocol 
 Synchronization of the estrus cycle consisted of an estrus pre-sync protocol beginning at 
30 DIM and a traditional Ovsynch® protocol plus controlled internal drug-release insert (CIDR®). 
The synchronization protocols were performed as previously described in Acosta et al. [21].  
 
Blood collection and analysis 
 Blood samples were obtained from the coccygeal artery or vein at 15, 30, and 73 DIM. 
Blood was collected into a vacutainer tube that contained EDTA anticoagulant (Vacutainer; 
Becton, Dickinson and Co., Franklin Lakes, NJ). After collection, the blood tubes were transferred 
on ice and placed into a temperature controlled centrifuge set at 4°C and centrifuged for 30 min at 
2000×g for sufficient separation of plasma. The plasma was then aliquoted into two 2 mL 
microcentrifuge tubes and stored at -80°C until they were analyzed. Analysis of amino acids and 
various metabolites (i.e. a-amino-adipic acid, a-amino-n-butyric acid, carnosine, citrulline, 
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cystathionine, cystine, γ-amino-butyric acid, homocystine, hydroxylysine, hydroxyproline, 
ornithine, phosphoserine, sarcosine, taurine, urea, 1-methyl-histidine, and 3-methyl-histidine) 
were conducted at the University of Missouri Agricultural Experiment Station Chemical 
Laboratories (Columbia, Missouri, USA).   
 
Cytology of the uterine endometrium 
 Cytology of the endometrium was performed using a cytology brush (Andwin Scientific, 
CA, USA) at 15, 30, and 73 DIM. The sterile cytology brush was mounted to a sterile stainless 
steel cytology rod and inserted into a larger sterile stainless steel rod (SSR) covered with a plastic 
sleeve for easy passage through the cervix and into the uterine body without contamination. Prior 
to the procedure, the cow was restrained and the vulva was cleaned with water and 70% ethanol. 
After passage of the cytology rod through the first ring of the cervix, the SSR was exposed through 
the plastic sleeve and advanced into the uterine body. Once inside the uterine body, the outer SSR 
was pulled back to expose the cytology brush. The SSR mounted to the cytology brush was then 
rotated three times while the brush remained in contact with the endometrium. Finally, the 
cytology brush was retracted back into the outer SSR and removed from the reproductive tract. 
 Cytology slides were prepped immediately following the procedure by rolling the cytology 
brush onto a clean glass microscope slide and fixed using a cytology fixative (Cytoprep, Thermo 
Fisher Scientific, Pittsburg, PA, USA). Once the fixative was dry, the samples were transported to 
the laboratory where they were stained with a differential stain (Camco Quik Stain 2 – Self 
Buffered Differential Wright-Giemsa Stain, Cambridge Diagnostic Products, FL, USA). After 
being allowed to dry for 24 h, the slides were covered using a mounting medium (Permount, 
Thermo Fisher Scientific) and dried for at least 48 h before being scanned. Images were obtained 
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at the Institute for Genomic Biology at the University of Illinois using whole slide imaging with a 
20X objective (Nanozoomer Digital Pathology System, Hamamatsu Photonics, Japan). Five 
images were captured from five separate locations, one image from each corner of the slide and 
one image from the center, to represent the entire population of the slide (NDP.view software, 
Hamamatsu Photonics). A minimum of 100 cells were counted within the individual areas using 
ImageJ (version 1.47, National Institutes of Health, MD, USA) and the proportion of PMN to 
epithelial cells was determined. The cell counting was performed by the same trained technician.  
 
Uterine endometrial biopsy  
 Uterine biopsies of the endometrial lining were performed at 15, 30, and 73 DIM using the 
Eppendorf Biopsy Forcep (Aries Surgical, Davis, CA, USA). Once the cow was restrained, the 
hair above the intercoccygeal space was trimmed and disinfected with iodine scrub solution and 
70% ethanol before lidocaine (5 mL, 2% lidocaine hydrochloride solution, Hospira Inc., Lake 
Forest, IL, USA) administration into the intercoccygeal space. The vulva and perineal area were 
cleaned with water, dried, and finally cleaned with 70% ethanol. Biopsy gun placement into the 
reproductive tract was performed similarly to the previously described cytology procedure. Once 
inside the uterine body, the biopsy gun was opened and a piece of endometrial tissue was 
positioned inside the forcep of the gun via transrectal palpation. The tissue was removed from the 
biopsy gun with sterile forceps and either placed into sterile DNA/RNA free Cryovial tubes 
(Simport, Beloeil, Quebec, Canada) and frozen in liquid nitrogen or placed in 10% formalin and 
taken to the University of Illinois College of Veterinary Medicine Comparative Biosciences 
Histology Laboratory for paraffin fixation.  
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Immunolabeling with glutathione peroxidase 1 and superoxide dismutase 1  
The staining performed by the histology lab included 1) Hematoxylin and Eosin, 2) 
glutathione peroxidase 1 (antibody dilution 1:100, GPX, ab59546, Abcam, Cambridge, UK), and 
3) superoxide dismutase 1 (antibody dilution 1:100, SOD, ab13498, Abcam, Cambridge, UK) and 
were stained according to the immunohistochemistry protocol of the lab. In brief, slides were de-
paraffinized in graded alcohols and steamed for 1 h in citrate buffer (pH = 6). Samples were then 
blocked using 3% (v:v) hydrogen peroxide for 10 min and washed with tris-buffered saline (TBS). 
Tissues were blocked using using background buster (NB306, Innovex Biosciences, Richmond, 
CA, USA) and solutions containing the primary antibodies were added to the tissue and then 
incubated for specific times (either GPX for 1 h or SOD for 2 h) were incubated at room 
temperature. The slides were washed 3 times with TBS then incubated with the secondary antibody 
(Rabbit on Rodent HRP-Polymer, RMR 622, Biocare Medical, Pacheco, CA, USA) for 30 min. 
Finally, the samples were washed with TBS (3 times for 5 min each), stained with DAB (Innovex 
Biosciences, Richmond, CA, USA) and counter stained with hematoxylin before being dehydrated 
and mounted. Slides were scanned using whole slide imaging with a 20X objective (Nanozoomer 
Digital Pathology System, Hamamatsu Photonics, Japan). 
 
Fluorescent immunolabeling with neutrophil elastase antibody  
 Slides that contained tissue samples were deparaffinized and hydrated with xylene (100%, 
2 times for 5 min each), ethanol (100% and 95% 2 times for 3 min, 80% and 70% 1 time for 3 min 
each), and phosphate buffer solution (PBS, 2 times for 3 min each). Slides were then placed into a 
citrate buffer solution [2.94 g tri-sodium citrate, 1000 mL distilled water, 1 N HCL for pH = 6, 
and 0.5 mL of 0.05% (w:v) Tween 20 (0.1% [v:v], 9005-64-5, Thermo Fisher Scientific, Waltham, 
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MA, USA)] and autoclaved for 20 min for antigen retrieval. Once cooled, the samples were washed 
with PBS (3 times) and permeabilized for 5 min using PBS with Tween 20 (PBST, 0.1% [v:v]). 
Following permeabilization, tissue samples were blocked for 1 h using goat serum (5% [v:v], 
Sigma, St. Louis MO) with PBST (0.1% [v:v]) at room temperature (~21°C). The neutrophil 
elastase antibody (diluted 1:1000, NE, ab68672, Abcam, Cambridge, UK) was diluted with PBST 
(0.1% [v:v]) and incubated on the tissue for 16 h at 4°C. After the incubation, the samples were 
washed with PBS (3 times for 5 min each) then incubated with an Alexa Fluor 488 conjugated 
goat-anti-rabbit antibody (A11034, Life Technologies Thermo Fisher Scientific, Waltham, MA, 
USA) at a concentration of 1:1000 with PBST (0.1% [v:v]) and 5% (v:v) goat serum for 1 h at 
room temperature in the dark. After being washed with PBS (3 times for 5 min each), the samples 
were stained with a nucleic acid Hoechst 33342 stain (H3570, Fisher Scientific) at a concentration 
of 1 µg/mL 1 min and then washed with PBS (3 times). The samples were cover slipped with a 
mounting medium (Flouromount-G, 0100-01, SouthernBiotech, Birmingham, AL, USA) and 
stored at 4°C until analyzed. 
 
Neutrophil count and neutrophil elastase intensity analysis 
 Biopsy sample slides stained with NE and DNA were scanned using an automated imaging 
cytometer (iCyte, Thorlabs Inc., Newton, NJ, USA) with a 20X objective. Software was set to only 
count fluorescent instances that contained both blue (DNA, 405 nm) and green (NE, 488 nm) 
fluorescence, thereby confirming the presence of a neutrophil. Additionally, 3D z-stack images of 
five areas from each tissue section were captured with a 63X oil objective of a confocal fluorescent 
microscope (Zeiss LSM 700, Zeiss, Oberkochen, Germany). Image settings remained the same for 
all samples to ensure accurate analysis of intensity: power (NE = 64.7 nm, DNA = 13.9 nm), image 
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size (72.5 μm x 72.5 μm), frame size (852 x 852 pixels), and pinhole size (41.2 AU). Finally, 
intensity levels of NE without background were acquired using the Axiovision Software (version 
4.7, Carl Zeiss MicroImaging GmbH, Jena, Germany). 
 
Hematoxylin and eosin stain for endometrial gland analysis 
 After whole image scanning, individual gland structures were labeled and images were 
captured (NDP.view software, Hamamatsu Photonics, Japan). Total glandular area and perimeter, 
glandular epithelial height, number of glandular epithelial cells, and number of glands per tissue 
sample were measured and calculated by the ImageJ software (version 1.47, National Institutes of 
Health, MD, USA). All glandular measurements were obtained by the same trained technician.  
 
Immunolabeling with anti-glutathione peroxidase 1 and anti-superoxide dismutase 1 antibody 
 After whole image scanning, 10 images were captured with a 40X objective (NDP.view 
software, Hamamatsu Photonics, Japan) and the percentage of positive cells were obtained by 
counting the number of positively and negatively immunolabeled cells (ImageJ version 1.47, 
National Institutes of Health, MD, USA). All slides were counted by the same trained technician. 
 
Statistical analyses 
 Statistical analyses were performed using SAS 9.4 (SAS Institute Inc. Cary, NC, USA). 
The MIXED procedure of SAS was used to analyze plasma amino acid and metabolite 
concentrations, glandular morphology, immunolabeling of GPX and SOD, PMN proportion, 
neutrophil counts, and NE intensity. The model for the previously stated response variables 
contained the fixed effects of treatment, time (DIM), and their interaction. Cow was considered 
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the experimental unit and included as a random effect. Residual distribution was evaluated for 
normality and homoscedasticity of variance in all analyses and transformations were used where 
appropriate. The covariance structure used was type = simple for all models for convergence of 
variance.  
 A logarithmic transformation was used for isoleucine, aspartic acid, glutamic acid, glycine, 
a-amino-adipic acid, a-amino-n-butyric acid, carnosine, γ-amino-butyric acid, 1-methyl-histidine, 
and neutrophil counts for normality and homogeneity of residuals. A square root transformation 
was used for valine, cystine, tyrosine, citrulline, homocystine, hydroxylysine, phosphoserine, urea, 
3-methyl-histidine, and the total number of glands per tissue for normality and homogeneity of 
residuals. Least squares means shown for these variables were not transformed. Extreme outliers 
were removed for cystine (n = 1), hydroxylysine (n = 4), phosphoserine (n = 1), and neutrophil 
counts (n = 1).  
 Frequency analysis was performed using the FREQ procedure of SAS considering the 
binary response variables of subclinical endometritis and immunolabeling of GPX and SOD 
scoring using the chi-square probability. Cows were considered to have subclinical endometritis 
based on the percentage of PMN: if greater than 18% at 30 DIM and 5% at 73 DIM [10, 14]. Cutoff 
values for 15 DIM have not been established or reported, therefore, our cutoff (36%) was 
determined by taking the median value of the data set for PMN percentage at 15 DIM. For GPX 
data, cows were considered to have a high score of positively immunolabeled cells if the 
percentage of positive to negatively labeled cells was greater than 84% at 15 DIM, 76% at 30 DIM, 
and 72% at 73 DIM. For SOD data, cows were considered to have a high score of positively 
immunolabeled cells if the percentage was greater than 44% at 15 DIM, 48% at 30 DIM, and 38% 
at 73 DIM. All cutoff values for GPX and SOD are derived from the median values of the data set 
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at each given DIM. Statistical significance was declared as P < 0.05 and a tendency declared at 
0.05 ≤ P ≤ 0.10.  
 
RESULTS 
Values for BW were (mean ± SD): week -3 to 0 = 774.61 ± 74.0 kg, week 1 to 4 = 671.42 
± 66.8 kg, and week 5 to 10 = 631.06 ± 52.3 kg. Values for BCS were (mean ± SD): week -3 to 0 
= 3.53 ± 0.4, week 1 to 4 = 3.13 ± 0.4, and week 5 to 10 = 2.89 ± 0.2. Values for DMI were (mean 
± SD): week -3 to 0 = 13.57 ± 2.8 kg/d, week 1 to 4 = 18.50 ± 4.7 kg/d, and week 5 to 10 = 22.85 
± 3.4 kg/d. Finally, milk yield values were (mean ± SD): week 1 to 4 = 42.7 kg/d and week 5 to 
10 = 48.9 kg/d. 
Blood plasma amino acid and metabolite concentrations are in Table 2.1. Plasma from 
cows in MET (30.39 ± 1.6 μM) had greater (P < 0.01) methionine concentrations than cows in 
CON (18.05 ± 2.0 μM). No treatment differences (P > 0.10) were observed for any other 
dispensable or indispensable amino acids in plasma. A tendency for a treatment by time interaction 
was detected for arginine (P = 0.11) and glutamine (P = 0.09) (Figure 2.1). 
 Plasma cystine concentrations were greater (P < 0.01) for cows in CON (3.62 ± 0.35 μM) 
than cows in MET (2.80 ± 0.28 μM). Cows in MET (23.68 ± 1.7 μM) had greater (P = 0.04) a-
amino-n-butyric acid plasma concentrations than cows in CON (17.24 ± 2.1 μM). Likewise, 
plasma concentrations of carnosine were greater (P < 0.01) for cows in MET (26.28 ± 1.7 μM) 
than cows in CON (15.19 ± 2.1 μM). Treatment differences were observed for cystathionine and 
γ-amino-butyric acid: cows in MET (2.61 ± 0.17 μM) had greater (P < 0.01) plasma cystathionine 
concentrations than cows in CON (1.50 ± 0.21 μM) and cows in MET (4.06 ± 0.40 μM) also had 
greater (P < 0.01) plasma γ-amino-butyric acid concentrations than cows in CON (1.29 ± 0.49 
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μM). Plasma homocystine concentrations were greater (P = 0.02) for cows in MET (5.77 ± 0.47 
μM) than cows in CON (3.99 ± 0.58 μM). Alternatively, cows in CON (19.63 ± 1.32 μM) had 
increased (P < 0.01) plasma sarcosine concentrations than cows in MET (12.56 ± 1.08 μM). 
Finally, cows in MET (51.07 ± 3.69 μM) had greater (P < 0.01) plasma taurine concentrations than 
cows in CON (30.05 ± 4.50 μM). A treatment by time interaction was detected for cystine (P = 
0.11) and hydroxylysine (P = 0.007) (Figure 2.2).  
 Analysis of glandular morphology and expression of GPX and SOD are in Table 2. A 
tendency for a treatment by time interaction was observed for glandular perimeter (P = 0.07) and 
number of glands per tissue (P = 0.06) (Figure 2.2). Analysis of glandular epithelial height and the 
number of cells per gland revealed a treatment by time interaction (Figure 2.2; Table 2.2). Finally, 
cows in CON tended to have a higher (P = 0.08) frequency (n = 4) of being classified as having a 
high score for GPX at 15 DIM (Table 2.3) than cows in MET (n = 1). Caution is advised when 
considering the results of the frequency analysis due to small sample size.  
 Data for the proportion of PMN, number of neutrophils, and NE intensity are in Table 2.2. 
A tendency for a treatment by time interaction (P = 0.09) was observed for cows in MET having 
greater PMN percentages than cows in CON at 15 DIM, but lower at 30 and 73 DIM (Figure 2.2). 
Cows in MET tended (P = 0.09) to be classified as not having subclinical endometritis (Table 2.4) 
at 30 DIM (n = 0) as compared to cows in CON (n = 2).  Similar to the frequency analyses for 
GPX, the small number of cows per treatment and the large amount of variation that accompanies 
categorical data demand that these data be interpreted with caution.  
 While treatment had no effect on neutrophil counts (P > 0.74), supplementation of RPM 
revealed a tendency for a treatment by time interaction (Figure 2.3, P = 0.06). Finally, we observed 
the formation of neutrophil extracellular traps in the bovine endometrial tissue at 15, 30, and 73 
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DIM (Figure 2.3). However, treatment differences were not observed for NET formation based on 
NE intensity (P > 0.93). 
 
DISCUSSION 
 The aim of this study was to evaluate the impact of feeding RPM on plasma amino acid 
and metabolite concentrations, endometrial glandular morphology, uterine neutrophil infiltration, 
neutrophil function (NET formation), and expression of SOD, GPX, and NE in the endometrial 
lining of dairy cows during the postpartum period. We postulated that supplementation of RPM, 
a limiting amino acid in dairy cattle, would increase the availability of other essential amino 
acids and metabolites leading to improved uterine glandular function and immune function, 
ultimately impacting overall reproductive health.   
Upon supplementation of RPM, there was a significant difference in plasma methionine 
concentrations between treatments. Sulfur-containing amino acids and derivatives are connected 
through a major metabolism pathway where methionine is broken down into homocysteine, 
cystathionine, cysteine, and results in taurine synthesis [22]. Similar plasma concentration 
outcomes were observed in Zhou et al. [8] after supplementation of RPM. The observed increase 
of circulating concentrations of the measured sulfur-containing compounds, except cystine, 
suggested that the cows supplemented with RPM have enriched sulfur-containing compounds 
available for alternative uses. Cystine is the product of two cysteine molecules joined together by 
a disulfide bond [23]. While the increased concentrations of cystine for cows in CON is not well 
understood, there may be possible down regulation of the conversion of cysteine into cystine 
upon supplementation of methionine in order to continue the synthesis of other sulfur-containing 
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compounds. On the other hand, abomasal infusion of methionine resulted in increased plasma 
cystine concentrations in non-lactating ruminants (steers and sheep) [24, 25]. 
 Previous studies have shown an increase in a-amino-n-butyric acid plasma 
concentrations, similar to the current study, which may be explained by the increase in sulfur-
containing compound concentrations, resulting in increased trans-sulfuration flux [26]. 
Carnosine is known as an antioxidant compound that has been shown to decrease oxidative stress 
in in vivo models and increase the antioxidant capabilities of various enzymes [27]. Therefore, 
the increased carnosine concentrations upon supplementation of RPM may suggest that oxidative 
stress can be prevented or reduced. Sarcosine is the product of glycine methylation with the 
enzyme glycine N-methyltransferase [28]. Since plasma methionine and homocystine 
concentrations were increased in cows supplemented with RPM, there may be down regulation 
of sarcosine into glycine, resulting in the lowered sarcosine plasma concentrations. Likewise, 
arginine and glutamine are connected to the methionine metabolism pathway via S-
adenosylmethionine and S-andenosylhomocystine. Therefore, supplementation of RPM may 
have increased various components, such as arginine and glutamine, which are connected to this 
pathway.  
Gamma-amino-butyric acid is an inhibitory neurotransmitter that is known to result in 
increased DMI when supplemented [29]. Since γ-amino-butyric-acid results in increased DMI, it 
could be hypothesized that γ-amino-butyric acid is the regulating factor for DMI via methionine 
supplementation, due to increased concentrations of γ-amino-butyric acid [7]. Finally, 
hydroxylysine is one of the main constituents of protein that can be found in collagen and has 
been found to increase endogenous levels when collagen is broken down [30]. Uterine involution 
is typically completed within 56 days after calving in dairy cows [31]. Therefore, the increased 
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hydroxylysine concentrations at 30 DIM for cows in MET may suggest decreased time for 
uterine involution due to increased collagen break down as described by Kiracofe [32]. 
 Holstein cows are three times more likely to develop metritis for every 1 kg decrease in 
DMI during the first week after calving [33]. Moreover, cows that showed evidence of postpartal 
uterine disease had increased lymphocytic foci (containing B and T-cells) and fibrosis in the 
uterine endometrium during gestation, which may lead to early embryonic death [17]. Recently, 
a new diagnostic technique utilizing endometrial biopsies has shown a deeper understanding of 
the bovine endometrium in the postpartum period [34]. Ohtani et al. [35] classified the changing 
glandular morphology of a normally cycling heifer in detail via uterine biopsy. Uterine 
endometrial biopsy samples that were classified as having severe inflammation contained 
noticeable glandular atrophy and necrosis [36]. Cows supplemented with RPM had altered 
glandular morphology (e.g.; greater perimeter at 15 DIM, Table 2.2), therefore, these cows may 
have had improved uterine immunity with lower inflammation during the postpartum period. 
Additionally, an influx in glandular number at 73 DIM, after the cow most likely had ovulated 
according to the synchronization protocol, correlates with the findings of increased glandular 
density in endometrial biopsies 8 d after the estrus cycle observed by Wang et al.  [37]. 
 In a study conducted on beef cows, it was observed that cows with large follicles and 
large corpus luteum exhibited higher GPX antioxidant activity as compared to cows that had 
small follicles and small corpus luteum, suggesting that uterine receptivity and fertility are 
associated with an optimal redox environment [38]. Likewise, the human endometrium has 
shown increased SOD antioxidant activity during the peri-implantation phase of pregnancy 
[39].These results are not in agreement with the observations from the current study. A possible 
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explanation for this outcome is that the bovine uterine environment during the trial did not 
contain redox challenges that required the assistance of GPX or SOD.  
 An increased PMN percentage for endometrial cytological findings in the early 
postpartum period has traditionally led to the diagnosis of subclinical endometritis [40 - 42]. In 
contrast, the increased infiltration of PMN in the uterine lumen could be an indicator of a robust 
immune response after calving as previously hypothesized by LeBlanc [11], which we observed 
in cows supplemented with RPM. These data support our hypothesis that the uterine immunity of 
cows supplemented with RPM may be improved in the postpartum period. Likewise, during the 
early postpartum period, it was observed that neutrophil numbers in the endometrial tissue were 
increased while PMN percentage slowly declined for uterine cytology. To the best of our 
knowledge, previous literature has not explained or observed the number of neutrophils present 
in the endometrium. It is possible that the neutrophils were mobilized to the uterine lumen after 
calving to assist with pathogen evasion and placental tissue removal around 15 DIM, and at 30 
DIM, the neutrophil counts in the endometrial tissue increased to assist with uterine involution. 
A similar explanation regarding neutrophil infiltration into the uterine lining of mice was 
concluded by Rinaldi et al. [43]. Cows in NEB, diagnosed with retained placenta or uterine 
disorders, had decreased blood PMN function in the peripaturient period, further explaining that 
supplementation of methionine to prevent NEB is critical for neutrophil function and uterine 
immunity [44, 45]. 
 Neutrophils are one of the main effector cells of the innate immune response, and are 
known for their quick pathogen recognition and phagocytosis capabilities. Recently, neutrophil 
extracellular traps, composed of chromatin and antimicrobial granules, have been discovered as a 
new antimicrobial mechanism that is performed by neutrophils [46]. Neutrophil extracellular trap 
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formation has been studied in human blood challenged with A. fumigatus, endometrial mucus 
from mares diagnosed with endometritis that contained common bacteria for the disorder, and 
bovine blood that was challenged with E. coli [47 - 49]. For the first time, to the best of our 
knowledge, we have identified the presence of NET formation in bovine endometrial tissue 
samples without need for external pathogen stimulation. According to the current study, the NET 
formation does not appear to be limited by amino acids. While neutrophil extracellular traps have 
been described as a novel mechanism for infection confinement, further research pertaining to 
the function and extent of NET formation in bovine tissue may lead to increased understanding 
of immune function [50].  
 In conclusion, supplementation of RPM to Holstein cows during the transition period 
increased availability of the once limiting amino acid methionine and several metabolite 
concentrations in the postpartum period. Also, supplementation of RPM resulted in improved 
uterine immune function through improved glandular morphology, increased neutrophil 
infiltration number after calving, and observed neutrophil extracellular trap formation in bovine 
endometrial tissue for the first time.  
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FIGURES AND TABLES 
Days in Milk (DIM) 
Figure 2.1. Least squares means and associated standard errors of supplementing rumen-
protected methionine (MET, n = 11, ) or not (CON, n = 9, ) on plasma amino acid 
concentrations for arginine (A), lysine (B), methionine (C), cystine (D), glutamine (E), and 
hydroxylysine (F). Lysine and methionine plots are included due to each being considered a 
limiting amino acid in dairy cows [4].   
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Days in Milk (DIM) 
Figure 2.2. Least squares means and associated standard errors of supplementing rumen-
protected methionine (MET, n = 11, ) or not (CON, n = 9, ) on uterine endometrial glandular 
morphology (A-D), percentage of polymorphonuclear neutrophils (PMN) (E), and the number of 
neutrophils present in endometrial tissue samples (F).  
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Figure 2.3. Paraffin embedded bovine endometrial tissue samples were stained with Hoechst 
(blue) and Neutrophil elastase (green) to reveal neutrophils (A-C). Samples were stained with blue 
Hoechst DNA stain (A) to confirm the presence of a nucleus and Anti-Neutrophil Elastase 
antibody 1 (B) that was fluoresced with green to confirm that the cell is a neutrophil. Together, the 
merged image (C) confirms that the neutrophils are performing NETosis (white arrow) in the 
bovine endometrial tissue. Scale bar is 10 µm.  Likewise, neutrophils (black arrow) and the 
neutrophil extracellular traps can be seen with a basic hematoxylin and eosin stain (D).  Scale bar 
is 20 µm.
A 
C D 
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Table 2.1. Least squares means and associated standard errors of plasma amino acids and various 
metabolites at 15, 30, and 73 days in milk from Holstein cows supplemented with rumen protected 
methionine (MET) or not (CON) from 21 days before calving until 73 DIM. 
 Treatment  P-value 
Amino Acids and Metabolites CON1 MET2 SEM TRT DIM3 TRT × DIM 
Indispensable, μM  
Arginine 59.71 65.69 4.89 0.36 0.47 0.11 
Histidine 50.04 52.71 2.94 0.49 0.01 0.70 
Isoleucine 100.36 95.15 6.29 0.56 0.004 0.52 
Leucine 167.84 159.54 10.84 0.56 0.01 0.74 
Lysine 66.73 69.59 5.60 0.70 0.10 0.14 
Methionine 18.05 30.39 2.02 0.0002 0.03 0.62 
Phenylalanine 49.89 47.53 2.76 0.52 0.04 0.34 
Threonine 94.94 88.08 6.51 0.43 0.58 0.71 
Tryptophan 27.12 21.14 3.77 0.24 0.81 0.58 
Valine 252.78 249.24 15.54 0.91 0.19 0.77 
Dispensable, μM  
Alanine 248.44 252.37 17.69 0.87 0.69 0.92 
Asparagine 40.91 36.93 4.31 0.49 0.0004 0.75 
Aspartic acid 7.24 7.49 1.28 0.85 0.01 0.53 
Glutamine 216.69 218.06 11.64 0.93 0.004 0.09 
Glutamic acid 48.45 52.12 5.69 0.62 <0.0001 0.98 
Glycine 400.62 385.92 26.62 0.45 <0.0001 0.90 
Proline 92.25 95.35 6.18 0.70 0.05 0.52 
Serine 95.95 89.88 5.07 0.37 <0.0001 0.53 
Tyrosine 49.87 46.57 3.83 0.53 0.52 0.87 
Metabolites,  μM  
 α-amino-adipic acid 11.06 9.67 1.20 0.53 0.32 0.62 
 α-amino-n-butyric acid 17.24 23.68 2.11 0.04 0.004 0.92 
 Carnosine 15.19 26.28 2.13 0.0006 0.47 0.61 
 Citrulline 91.15 89.63 5.64 0.88 0.52 0.81 
 
Cystathionine/Allocystathionine 
1.50 2.61 0.21 0.0008 0.05 0.17 
Cystine 3.62 2.80 0.35 0.009 <0.0001 0.11 
γ-amino-butyric acid 1.29 4.06 0.49 0.0014 0.28 0.95 
 Homocystine 3.99 5.77 0.58 0.02 0.37 0.93 
 Hydroxylysine 0.35 0.11 0.11 0.11 0.89 0.007 
 Hydroxyproline 13.89 13.65 0.88 0.84 <0.0001 0.99 
Ornithine 36.21 34.63 3.13 0.70 0.06 0.66 
Phosphoserine 6.78 7.22 0.42 0.37 0.04 0.37 
Sarcosine 19.63 12.56 1.32 0.0008 0.05 0.47 
Taurine 30.05 51.07 4.50 0.003 0.44 0.34 
Urea 4271.31 4311.95 323.98 0.92 0.13 0.93 
1-methyl-histidine 18.44 18.57 1.23 0.96 0.001 0.30 
3-methyl-histidine 5.07 4.84 0.30 0.43 <0.0001 0.88 
1CON = control, no rumen protected methionine, n = 7. 
2MET= rumen protected methionine, n = 10. 
3Days in milk.  
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Table 2.2. Least squares means and associated standard errors for glandular morphology, immunolabeling for glutathione peroxidase 1 and 
superoxide dismutase 1, proportion polymorphonuclear neutrophils (PMN), neutrophil number, and neutrophil elastase (NE) intensity per 
uterine endometrial tissue samples from Holstein cows supplemented with rumen protected methionine (MET) or not (CON) from 21 days 
before calving until 73 DIM. 
 
 
Treatment 
 
P-value 
 CON MET  
SEM 
Fixed effects 
Item d15 d30 d73 d15 d30 d73 TRT1 DIM2 TRT x DIM3 
Glandular Morphology4  
Glandular Area, 𝜇m2 1193.78 9562.26 5526.04 5006.61 5554.78 5961.02 2359.71 0.96 0.11 0.19 
Glandular Perimeter, 𝜇m 58.35 394.03 271.18 229.48 197.24 250.13 87.46 0.80 0.11 0.07 
Glandular Epithelial Height, 𝜇m 3.14 17.46 14.69 11.52 6.86 12.95 3.83 0.62 0.10 0.03 
Number of Cells per Gland 4.30 25.55 18.18 14.24 9.55 17.65 5.36 0.57 0.09 0.03 
Number of Glands 3.17 63.38 86.83 22.58 14.60 188.00 50.69 0.70 0.004 0.06 
Immunolabeling4  
Glutathione Peroxidase, % 87.35 66.11 61.83 69.20 71.82   70.19 9.52 0.84 0.25 0.18 
Superoxide Dismutase, % 47.99 43.74 37.36 41.71 47.40 36.60 11.77 0.89 0.59 0.89 
PMN Proportion5, % 38.98 24.46 21.39 45.59 5.30 3.67 10.16 0.34 <0.0001 0.09 
Number of Neutrophils4 1481.40 488.05 2302.47 921.79 1432.18 1223.66 627.65 0.74 0.48 0.06 
NE Intensity4,6 39.46 41.00 41.38 40.64 40.01 42.07 4.11 0.93 0.85 0.94 
1TRT = Treatment: Control (CON) = no supplementation or Methionine (MET) = supplementation of rumen-protected methionine. 
2DIM = Days in milk from calving (day = 0). 
3TRT x DIM = Treatment by days in milk interaction.  
4Day 15 (CON = 6, MET = 6), Day 30 (CON = 4, MET = 5), and Day 73 (CON = 6, MET = 10).  
5Day 15 (CON = 9, MET = 10), Day 30 (CON = 7, MET = 9), and Day 73 (CON = 6, MET = 10).  
6Intensity of green fluorescence from NETs without background in arbitrary units. 
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Table 2.3. Frequency of uterine endometrial samples having a high or low score1 for positively labeled epithelial cells 
for Glutathione Peroxidase 1 antibody and Superoxide Dismutase 1 antibody from Holstein cows supplemented with 
rumen protected methionine (MET) or not (CON) from 21 days before calving until 73 DIM. 
  Treatment  
  CON MET 
P-value 
Item Day2 Low High Low High 
Glutathione Peroxidase, %  
 
15 2 4 5 1 0.08 
30 2 2 2 3 0.76 
73 3 3 5 5 1.00 
Superoxide Dismutase, %  
 
15 2 4 4 2 0.25 
30 2 2 2 3 0.76 
73 3 3 5 5 1.00 
1Cutoff values for samples being classified as high or low scores: GPX: Day 15 (Low = < 84%, High = > 84%), Day 30 (Low = < 76%, High = > 76%), and 
Day 73 (Low = < 72%, High = > 72%) and SOD: Day 15 (Low = < 44%, High = > 44%). Day 30 (Low = < 48%, High = > 48%), and Day 73 (Low = < 
38%, High = > 38%).  
2Days in milk: Day 15 (CON = 6, MET = 6), Day 30 (CON = 4, MET = 5), and Day 73 (CON = 6, MET = 10).   
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Table 2.4. Frequency of cows diagnosed with subclinical endometritis based on the 
proportion of polymorphonuclear neutrophils (PMN) from uterine endometrial cytology 
samples  from Holstein cows supplemented with rumen protected methionine (MET) or not 
(CON) from 21 days before calving until 73 DIM. 
 Treatment  
 CON MET 
P-value 
Day2 No3 Yes4 No Yes 
15 5 4 5 5 0.81 
30 5 2 9 0 0.09 
72 5 1 8 2 0.87 
1Cutoff values for samples being classified as having subclinical endometritis: Day 15: > 36%, Day 30: > 18%, and Day 
72: > 5 %.  
2Days in milk: Day 15 (CON = 9, MET = 10), Day 30 (CON = 7, MET = 9), and Day 73 (CON = 6, MET = 10).   
3No = Not being classified as having subclinical endometritis. 
4Yes = Being classified as having subclinical endometritis  
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CHAPTER 3 
EFFECTS OF RUMEN-PROTECTED METHIONINE ON THE LIPID PROFILES OF 
THE PREIMPLANTATION EMBRYO AND ENDOMETRIAL TISSUE OF HOLSTEIN 
COWS 
 
ABSTRACT 
 Balanced maternal nutrition has the potential to influence embryonic development and 
survival. The objective of this study was to identify lipid profiles in the preimplantation embryo 
and endometrial tissue of Holstein cows supplemented with rumen-protected methionine (RPM) 
during the transition period and early lactation. Multiparous cows (n = 20) were randomly assigned 
to two treatments starting at 21 d before calving until 73 days in milk (DIM). Treatments were: 
CON (n = 9, no supplementation, TMR with Lys:Met = 3.5:1) and MET (n = 11, TMR + 
Smartamine® M with Lys:Met = 2.8:1). Endometrial biopsies were obtained at 15, 30, and 73 DIM 
and preimplantation embryos were harvested at 73 DIM. Endometrial lipid profiles were analyzed 
using multiple reaction monitoring-profiling and lipid profiles of embryos were acquired using 
matrix assisted laser desorption/ionization mass spectrometry. Relative intensities levels were used 
for principal component analysis, principle components with a proportion >10% were extracted, 
and loadings in the top 5% were discussed. Cows in MET (25.90 ± 1.1) had increased 
polyunsaturated lipid amounts in embryos than cows in CON (17.07 ± 1.4). Cows in CON (10.51 
± 0.86) had increased amounts of saturated lipids in uterine tissue at 15 DIM than cows in MET 
(8.50 ± 0.9). Cows in CON (13.16 ± 1.1) had increased amounts of un/monounsaturated lipids in 
uterine tissue at 15 DIM than cows in MET (10.62 ± 1.1). Cows in MET (40.21 ± 10.9) had 
increased saturated lipid amounts in uterine tissue at 30 DIM than cows in CON (9.48 ± 12.2). 
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Cows in MET (90.26 ± 7.0) had increased amounts of unsaturated lipids in uterine tissue at 30 
DIM than cows in CON (64.99 ± 7.8). Cows in MET (39.20 ± 5.8) had increased monounsaturated 
lipid amounts in uterine tissue at 30 DIM than cows in CON (12.59 ± 6.5). Saturated lipid amounts 
in uterine tissue at 73 DIM were increased for cows in MET (45.36 ± 7.4) than cows in CON 
(20.25 ± 9.4). Cows in MET (100.50 ± 10.2) had increased amounts of unsaturated lipids in uterine 
tissue at 73 DIM than cows in CON (70.74 ± 13.0). Finally, cows in MET (43.88 ± 4.7) had 
increased monounsaturated lipid amounts in uterine tissue at 73 DIM than cows in CON (24.38 ± 
5.8). In conclusion, specific lipid classes and lipid unsaturation level of preimplantation embryos 
and endometrium tissue of cows fed RPM were altered, which may be indicative of improved 
embryonic vitality.  
 
Key words: Methionine, lipid profiling, embryo, endometrium. 
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INTRODUCTION 
 The link between balanced maternal nutrition and embryonic development is 
crucial during gestation [1]. Maternal nutritional deficiencies may lead to delayed 
metabolic development of the embryo, resulting in predisposed deficiencies due to 
disturbance of epigenetic mechanisms [1]. Reductions in B vitamins and methionine have 
resulted in altered epigenetics and DNA methylation of offspring, leading to modified adult 
health-related phenotypes in sheep [2]. Moreover, development and synthesis of proteins 
in the fetus depend on a balance of non-dispensable and dispensable amino acids, 
signifying the importance of nutrition in embryonic development [1].  
 Multiple studies have established the importance of implementing nutritional 
strategies to improve fertility in dairy cows [3-5]. Methionine is considered to be one of 
the most limiting amino acids in dairy cows [6]. Supplementation of rumen-protected 
methionine (RPM) has been recommended, as compared to free methionine, due to 
increased ruminal bypass, leading to absorption in the small intestine and increased 
circulating plasma methionine concentrations for utilization [6-9]. Methionine is 
commonly recognized as a methyl donor that aids in the synthesis of phospholipids as well 
as a lipotropic agent which can assist with lipid removal from the liver through stimulation 
of very low density lipid formation [10]. Therefore, dietary supplementation of methionine 
could possibly increase the availability of various lipids. While supplementation of RPM 
during the transition period has led to increased postpartum performance in dairy cows, 
maternal methionine supplementation has been shown to alter the transcriptome of bovine 
blastocyst involved in embryonic and adult functions [11-12]. Additionally, 
supplementation of RPM increase gene expression of 3β-HSD, which aids in synthesis of 
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progesterone, possibly improving pregnancy maintenance [13]. Bonilla [14] suggested that 
the methionine requirement for preimplantation embryos was between 14 and 21 μM/L. 
Acosta et al. [13] observed increased methionine concentrations in the follicular fluid 
retrieved from cows that had been supplemented with RPM, signifying how dietary 
methionine can reach the follicles that contain oocytes. While the direct effect of 
methionine on the development of the preimplantation bovine embryo has not been 
discovered, addition of 20 amino acids in media resulted in an increased number of cells 
in blastocyst, suggesting improved growth in alternate studies [15]. Furthermore, Acosta 
et al. [16] fed RPM to Holstein cows during the transition period and observed an increase 
in preimplantation embryo lipid accumulation.   
 Lipid diversity and accumulation in oocytes varies greatly between species [17]. 
McEvoy et al. [17] discovered that the fatty acid reserves in cattle, sheep, and pig oocytes 
contained at least 50% of palmitic and oleic acid with triglycerides being the most fatty-
acid rich fraction. A recent study regarding oocytes harvested from slaughterhouse cattle 
revealed an increase in lipid droplets in oocytes at the morula stage in addition to increased 
expression of genes, specifically ACSL3, related to lipid metabolism in preimplantation 
embryos at various developmental time points [18].  While limited research has been 
conducted in regards to the effect of RPM on lipid diversity and accumulation in the bovine 
embryo, one previous study observed increased lipid accumulation in preimplantation 
embryos with decreased DNA methylation upon RPM supplementation during the 
transition period [16]. Similarly, Warren et al. [19] confirmed previous observations of 
increased osmophilic lipids in a progesterone dominated rat uterus. However, the extent of 
lipid profiling and classification is limited in regards to the bovine uterus.  
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 The purpose of the present experiment was to study lipid profiles by class and 
unsaturation level in the preimplantation embryo and endometrial tissue of Holstein cows 
supplemented with RPM during the transition period and early lactation and relate these 
data to improved embryonic vitality.  
 
MATERIALS AND METHODS  
Experimental Design and Dietary Treatments 
 Procedures performed in the following experiment were approved by the University 
of Illinois (Urbana-Champaign) Institutional Animal Care and Use Committee (IACUC). 
Detailed procedure is described elsewhere [16].  Briefly, a total of 20 Holstein cows 
entering their second or greater lactation (parity 3.0 ± 1.2) were included in the experiment 
from 21 d before calving until 73 days in milk (DIM). Cows were housed in free stalls with 
individual Calan feed gates (American Calan Inc., Northwood, NH, USA) during the 
prepartum period and moved to individual maternity pens within the same barn before their 
expected calving date.  After parturition, all cows were housed in tie stall barns at the 
University of Illinois Urbana-Champaign Research Dairy Farm and milked three times a 
day. 
All cows received a complete total mixed ration (TMR) diet that met the energy 
requirements of the cows according to the NRC 2001 [6]. At 21 d before calving, cows 
were randomly assigned to one of two treatments, which were given as a top-dress on the 
TMR: 1) no supplementation; (CON; n = 9; Lys:Met = 3.5:1) or 2) supplementation with 
RPM; [MET; n = 11; RPM at a rate 0.08% of DM: Lys:Met = 2.8:1, (Smartamine ® M 
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Adisseo, Alpharetta, GA, USA)]. The dosage of RPM was established based on Zhou et al. 
[11].  
 
Synchronization, Superovulation, and Embryo Flushing Protocol 
 Detailed procedure is described elsewhere [16].  Briefly, synchronization of the 
estrus cycle consisted of an estrus pre-sync protocol beginning at 30 DIM and a traditional 
Ovsynch® protocol plus controlled internal drug-release insert (CIDR®). Previous follicles 
were ablated before superovulation treatment was initiated with intramuscular 
administration of FSH (Folltropin-V, Bioniche Life Sciences, Belleville, ON, Canada). 
Subsequent decreasing dosages of FSH were administered over a period of 4 days in 
addition to prostaglandin F2α (25 mg, intramuscular of dinoprost tromethamine; 5 mL of 
Lutalyse, Zoetis Animal Health, NJ, USA) and removal of the controlled internal drug-
release (CIDR; Eazi-Breed CIDR, Zoetis Animal Health). Artificial insemination was 
performed by the same technician at 12 and 24 h after administration of GnRH (100 μg, 
intramuscular, of gonadorelin hydrochloride; 2 mL of Factrel, Zoetis Animal Health). 
Finally, embryos were flushed and evaluated according to the manual of the International 
Embryo Transfer Society [19]. Embryos were exposed to 1.5 M EG cyroprotectant solution 
(Vigro Ethylene Gycol®, Bioniche Animal Health, Pullman, WA, USA) for 5 min and 
loaded into 0.25 mL plastic straws before being placed into a temperature controller 
(Freeze Control®, Margaret River, Western, Australia) at – 6.5 ºC. After a couple minutes, 
the straws were seeded, equilibrated for 10 min at – 6.5 ºC and cooled at – 0.6 ºC/min until 
the temperature reached – 35 ºC. Embryos were stored in liquid nitrogen until analysis.  
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Lipid Analysis of Embryos by MALDI-TOF-MS 
 Embryos from three cows (n = 8) that were quality = 1 and were at stage = 4 or 
greater according to the manual of the International Embryo Transfer Society were used 
for analysis [19].  Each embryo was washed in phosphate buffer solution (PBS) three times 
to remove media and 25% methanol two times to remove salts that may disturb ionization. 
Using a mouth pipette, the embryos were placed onto an Opti-TOF 384 well plate (Ab 
SCiex, Concord, Ontario, CA), and allowed to dry before being stored at – 80°C. Samples 
were analyzed via matrix-assisted laser desorption/ionization time-of-flight mass 
spectrometry (MALDI-TOF MS) at the Bindley Bioscience Center at the Discovery Park 
of Purdue University (West Lafayette, IN). Prior to analysis, a matrix was administered to 
the sample plate which consisted of 8000μL of TA30 solvent (30:70 [v/v] acetonitrile:0.1% 
TFA in water) to 160mg of 2,5-DHB (2,5–Dihydroxybenzoic acid) for a total volume of 
8mL of matrix solvent that was loaded and administered 16 times in a cross section pattern 
at 45°C by a matrix sprayer (HTX TM-Sprayer, HTX Technologies, Chapel Hill, NC, 
USA). From there, images and mass spectra were obtained in a MALDI 4800 TOF 
instrument (AB SCiex, Concord, Ontario, CA) while utilizing the 4000 Series Explorer 
Software (v3.7, AB SCIEX) in reflectron at the positive ion mode. All images were 
acquired with the 4800 Imaging Tool Software (www.maldi-msi.org, M. Stoeckli, Novartis 
Pharma, Basel, Switzerland) with an imaging raster of 100μm at 50 shots per subspectrum 
in the m/z range of 700 to 1,200.  
 
Endometrial Biopsy Collection and Lipid Analysis by MRM-Profiling 
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 Uterine biopsies of the endometrial lining were performed at 15, 30, and 73 days in 
milk (DIM) using the Eppendorf Biopsy Forcep (Aries Surgical, Davis, CA, USA). Once 
the cow was restrained, the hair above the intercoccygeal space was trimmed and 
disinfected with iodine scrub solution and 70% ethanol before lidocaine (5 mL, 2% 
lidocaine hydrochloride solution, Hospira Inc., Lake Forest, IL, USA) administration into 
the intercoccygeal space. The vulva and perineal area were cleaned with water, dried, and 
finally cleaned with 70% ethanol. Biopsy gun placement into the reproductive tract was 
performed through transrectal palpation and manipulation of the cervix. Once inside the 
uterine body, the biopsy gun was opened and a piece of endometrial tissue was positioned 
inside the forcep of the gun via transrectal palpation. The tissue was removed from the 
biopsy gun with sterile forceps, placed into sterile DNA/RNA free Cryovial tubes (Simport, 
Beloeil, Quebec, Canada), and frozen in liquid nitrogen.  
 Uterine biopsy samples from 20 cows were analyzed at the Bindley Bioscience 
Center using Multiple Reaction Monitoring-profiling (MRM) mass spectrometry. The 
uterine samples were homogenized and the lipids were extracted before the discovery 
phase of analysis using the Bligh and Dyer method [20]. The discovery phase consisted of 
analyzing two samples, one from each treatment, to identify the groups of lipids that were 
present in the samples. Methods used for the discovery phase are in Table 3.1.   
From there, the samples were delivered through a micro-autosampler (G1377A) 
into a triple quadrupole (QqQ) mass spectrometer (6460, Agilent Technologies, San Jose, 
CA). Selection of the parent ion occurred at the first quadrupole, collision induced 
dissociation caused fragmentation at the second quadrupole, and finally the fragment was 
monitored at the third quadrupole. Each sample was run through five different methods (4 
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methods for positive and 1 for negative ion mode) during the screening step to ensure 
accurate screening of the targeted lipids found during the discovery phase. Solvent (ACN 
+ 0.1% formic acid) was pumped through the mass spectrometer between each injection of 
sample. Further details regarding the MRM-profiling method have been described in 
Ferreira et al. [22].  
 
Statistical Analyses 
 Statistical analyses were performed using Metaboanalyst 3.0 
(www.metaboanalyst.ca) and SAS 9.4 (SAS Institute Inc. Cary, NC, USA). Lipid profiles, 
processed as relative ion count intensities (each ion in the mass spectrum has the ion counts 
divided by the total ion count of all ions in the mass spectrum) were used for analysis and 
10% of background in relation to the highest peak value was removed for the embryo data 
to reduce false positives. Principle component analysis (PCA) was performed by replacing 
values below the 10% threshold with means and auto scaling according to the 
Metaboanalyst software. Only auto scaling was applied for the uterine biopsy data due to 
background noise being removed during the discovery phase of analysis. All principle 
components (PCs) with proportions greater than or equal to 10% were extracted and the 
highest 5% loadings were discussed.  
Lipids were tentatively attributed based on the LipidMaps database 
(http://www.lipidmaps.org) considering a tolerance of 0.3 Da for embryos and 0.5 Da for 
uterine biopsies and Metlin (https://metlin.scripps.edu/index.php) considering a mass 
tolerance appropriated for the instruments used (0.4 Da for MALDI and up to unitary 
resolution for the QqQ). For uterine biopsies, lipid attribution was also pursued using on 
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METLIN (https://metlin.scripps.edu/index.php). For MALDI-MS data, a standard 
deviation of 0.4 Da was used for the theoretical masses m/z 708.90 and 732.90 due to 
limited attributions from the database. Additionally, the theoretical mass of m/z 710.90 was 
used to attribute the lipids for m/z 708.90 due to one unsaturation loss equaling 2 mass units 
for the embryo data.  Based on previous experience using MALDI and 2,5-
dihydroxybenzoic acid as a matrix, as well as tMS/MS of lipids that are present in oocytes, 
we only considered phosphatidylcholine (PC), sphingomyelin (SM), and triacylglycerol 
(TG) as possible lipids for the tentative attributions in the embryos.  
 Finally, variables that were considered to be important (i.e. loadings in the top 5%) 
according to the PCA were analyzed with the MIXED procedure of SAS. The model for 
the previously stated response variables contained the fixed effect of treatment. Cow was 
considered the experimental unit and was included as a random effect. Residual distribution 
was evaluated for normality and homoscedasticity of variance in all analyses. Statistical 
significance was declared as P ≤ 0.05 and a tendency declared at 0.05 < P ≤ 0.15. 
 
RESULTS 
Results for Embryo Lipid Analysis 
 Values of relative ion intensities that are not of statistical interest according to SAS 
were not included in the tables. In order to better explain which lipids were found in the 
embryos, four PCs were extracted from the PCA. These four PCs accounted for 85% of the 
total variability (Table 3.2). Tentative attributions for lipids of interest for embryos based 
on PCA are in Table 3.3. The extracted loadings (PC1: loadings ≥ 0.15459; PC2: loadings 
≥ 0.20502; PC3: loadings ≥ 0.19442; PC4: loadings ≥ 0.23844) indicate that PC1 represents 
  
67 
 
animals that have TG lipids present. Principle component 2 represents animals that mainly 
have PC lipids. Finally, PC3 represents animals that mainly have TG lipids in the embryos, 
whereas PC4 is an even mixture of TG, SM, and PC lipids (Table 3.4).  
 A distinct separation for treatments can be seen between PC1 and PC2 (Figure 3.1). 
Likewise, there was larger variation for cows in MET as seen by the enlarged oval as 
compared to cows in CON (Figure 3.1A).  For increased values of PC1, cows in MET also 
had increased values of PC2.  Alternatively, PCA revealed increased values of PC3 for 
cows in MET, which remained constant for PC4 (Figure 3.1B). It should also be noted that 
cows in MET have increased TG amounts as compared to cows in CON, seen in PC1, and 
cows in CON appear to have increased PC amounts as compared to cows in MET as seen 
on the PC2 axis.  
 Analysis of the relative amounts of lipids that were of interest based on PCA for 
embryos retrieved at 73 DIM are in Table 3.5. Cows in MET tended (5.05 ± 1.0) to have 
lower (P = 0.10) monounsaturated lipid amounts than cows in CON (8.32 ± 1.3). 
Alternatively, cows in MET (25.90 ± 1.1) had higher (P ≤ 0.05) polyunsaturated lipid 
amounts compared to cows in CON (17.07 ± 1.4).  
 
Results for Endometrial Biopsy Lipid Analysis at 15 DIM 
 Tentative attributions for lipids of interest for uterine endometrial biopsies obtained 
at 15 DIM based on PCA are in Table 3.7. The extracted loadings (Method 1: PC1 loadings 
≥ 0.077435; Method 2: PC1 loadings ≥ 0.093893 and PC2 loadings ≥ 0.17326; Method 3: 
PC1 loadings ≥ 0.095559 and PC2 loadings ≥ 0.14156; Method 4: PC1 loadings ≥ 0.087559 
and PC2 loadings ≥ 0.15073; Method 5: PC1 loadings ≥ 0.14552 and PC2 loadings ≥ 
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0.27031) are in Table 3.8. In order to better explain which lipids are found in the uterine 
endometrial biopsies obtained at 15 DIM, method 1 had one PCs extracted accounting for 
93.4% variability and methods 2-5 had 2 PCs extracted each accounting for 79.6, 83.9, 
85.3, and 91.9% variability, respectively. Grouping identification, while an added benefit, 
was not revealed for PC1 for methods 1, 2, 4, or 5. There was increased variation for cows 
in CON for method 1 at 15 DIM as seen in figure 2A. For method 2, PC2 represent animals 
that have TG lipids present for which cows in MET had the greatest variation (Figure 
3.3A).  
 Additionally, for method 3, PC1 mainly represents animals that have higher PC 
lipid amounts and PC2 represents animals that have PC and SM lipids present in the uterine 
tissue. Majority of the cows in MET fall below zero on the PC1 axis, indicating that cows 
in MET had decreased PC lipid amounts; similar can be said for cows in MET for PC2 
(Figure 3.4A).  Principal component 2, for method 4, represents animals that mainly have 
higher amounts of ceramides (CER). While cows in CON had larger variation, as denoted 
by increased circular area, cows in CON also had increased levels of CER more so than 
cows in MET (Figure 3.5A). Finally, PC2 of method 5 represents animals that have 
diacylglycerol (DG) in the uterine tissue. Cows in MET had increased DG lipid amounts 
as compared to cows in CON (Figure 3.6A).  
 Analysis of lipid markers that were of interest according to the PCA for 15 DIM 
are in Table 3.9. Cows in CON (10.51 ± 0.86) tended to have higher (P = 0.14) amounts of 
saturated lipids compared to cows in MET (8.50 ± 0.9). Similarly, cows in CON (13.16 ± 
1.1) tended to have higher (P = 0.13) amounts of unsaturated/monounsaturated lipids than 
cows in MET (10.62 ± 1.1).  
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Results for Endometrial Biopsy Lipid Analysis at 30 DIM 
 Tentative attributions for lipids of interest for uterine endometrial biopsies obtained 
at 30 DIM based on PCA are in Table 3.11. The extracted loadings (Method 1: PC1 
loadings ≥ 0.082637 and PC2 loadings ≥ 0.15433; Method 2: PC1 loadings ≥ 0.092384 and 
PC2 loadings ≥ 0.14449; Method 3: PC1 loadings ≥ 0.0884 and PC2 loadings ≥ 0.15648; 
Method 4: PC1 loadings ≥ 0.098898 and PC2 loadings ≥ 0.12144; Method 5: PC1 loadings 
≥ 0.14766 and PC2 loadings ≥ 0.27869) are in Table 12. 
 In order to better explain which lipid markers are found in the uterine endometrial 
biopsies obtained at 30 DIM, two PCs were extracted for methods 1-5 with the following 
variability: 97.5, 92.2, 85.5, 85.4, and 85.8% respectively. Identification of groups based 
on extracted loadings for methods 1, 2, and 5 did not reveal valuable information due to 
the vast possibilities of tentative lipids. This can also be seen in Figure 3.2B, 3.3B, and 
3.6B, cows from both treatments hover around zero, signifying that groups cannot be 
distinguished. For method 3 at 30 DIM, PC1 represents animals that mainly have TG and 
PC2 represents animals that have higher amounts of PC lipids present. Cows in MET 
contain a greater amount of variation as compared to cows in CON, while both treatments 
appear to have decreased amounts of TG as shown in Figure 3.4B. Principal component 1 
of method 4 at 30 DIM represents animals that have CER lipids present. Likewise, cows in 
CON had decreased amounts of CER as compared to cows in MET (Figure 3.5B) while 
cows in MET had greater variation as compared to cows in CON. 
 Analysis of lipids of interest according to the PCA for 30 DIM are in Table 3.13. 
Treatment effects were revealed for saturated and unsaturated lipids: cows in MET (40.21 
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± 10.9) tended to have increased (P = 0.10) saturated lipid amounts compared to cows in 
CON (9.48 ± 12.2) and cows in MET (90.26 ± 7.0) had increased (P ≤ 0.05) amounts of 
unsaturated lipids than cows in CON (64.99 ± 7.8). Finally, cows in MET (39.20 ± 5.8) 
had increased (P ≤ 0.05) monounsaturated lipid amounts compared to cows in CON (12.59 
± 6.5).  
 
Results for Endometrial Biopsy Lipid Analysis at 73 DIM 
 Tentative attributions for lipids of interest for uterine endometrial biopsies obtained 
at 73 DIM based on PCA are in Table 3.15. The extracted loadings (Method 1: PC1 loading 
≥ 0.078854; Method 2: PC1 loadings ≥ 0.10085, PC2 loadings ≥ 0.1695, and PC3 loadings 
≥ 0.21204; Method 3: PC1 loadings ≥ 0.099032, PC2 loadings ≥ 0.14595, and PC3 loadings 
≥ 0.16354; Method 4: PC1 loadings ≥ 0.090057 and PC2 loadings ≥ 0.13231; Method 5: 
PC1 loadings ≥ 0.14999 and PC2 loadings ≥ 0.30029) are in Table 3.16. In order to better 
explain which lipid markers are found in the uterine endometrial biopsies obtained at 73 
DIM, one PCs was extracted for method 1 accounting for 89.7% of the total variability. 
Three PCs were extracted for methods 2 and 3 accounting for 83.4 and 82.6% of the total 
variability. Finally, two PCs were extracted for methods 4 and 5 accounting for 82.0 and 
83.9% of the total variability.  
 Principle component one for method 1 at 73 DIM represents animals that have 
uterine biopsies that mainly contain DG lipids; Cows in CON had decreased amounts of 
DG lipids as compared to cows in MET (Figure 3.2C). While group identification could 
not be accomplished for PC1 of method 2, for 73 DIM, PC2 represents animals that have 
higher abundances of TG lipid amounts and PC3 represents animals that have higher DG 
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lipid amounts. Cows in both treatments had increased TG amounts and cows in MET had 
decreased amounts of DG lipids as compared to cows in CON (Figure 3.3C-D). Method 3 
at 73 DIM contained the following groups: PC1 represents animals that have higher 
amounts of PC lipids, PC2 represents animals that have higher amounts of SM lipids, and 
PC3 represent animals that have a mixture of PC and SM lipids. Cows in CON had 
decreased amounts of PC lipids as compared to cows in MET (Figure 3.4C). Additionally, 
cows in MET had decreased amounts of PC and SM lipids as compared to cows in CON 
(Figure 3.4D). In both instances, a large sample variation can be seen for cows in MET. 
While PC1 for method 4 at 73DIM could not be grouped, PC2 represents animals that have 
higher amounts of PC lipids present. Cows in MET had higher amounts of PC lipids as 
compared to cow in CON, as seen in Figure 3.5C. Finally, no groups were discovered for 
PC1 of method 5 at 73 DIM, however, PC2 represents animals that have higher DG lipid 
amounts. Cows in MET had increased amounts of DG lipids as compared to cows in CON 
as seen in figure 3.6C.  
 Analysis of lipids of interest according to the PCA for 73 DIM are in Table 3.17. 
Relative amounts of saturated lipids were higher (P = 0.06) for cows in MET (45.36 ± 7.4) 
compared to cows in CON (20.25 ± 9.4). Likewise, cows in MET (100.50 ± 10.2) had 
increased (P = 0.10) amounts of unsaturated lipids than cows in CON (70.74 ± 13.0). 
Treatment effects for monounsaturated lipids were observed; Cows in MET (43.88 ± 4.7) 
had increased (P ≤ 0.05) monounsaturated lipid amounts compared to cows in CON (24.38 
± 5.8). 
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DISCUSSION 
 The aim of this study was to observe the effects of dietary supplementation of RPM 
on lipid profiles of the preimplantation embryo and endometrial tissue of dairy cows during 
the postpartum period. We postulated that the lipid profiles, as well as unsaturation level, 
would be different in cows supplemented with RPM when compared with control, possibly 
indicative of improved embryo vitality. For the embryo lipid analysis, MALDI-TOF MS 
was used due to the limited amount of sample and the use of DHB as matrix results in lipid 
profiles of PC, SM and TAG lipids [23]. For the endometrial tissue samples, MRM-
profiling, a recently-developed method for first-pass discovery was used [24]. 
 Phosphatidylcholine and sphingolipids are common lipids present in mammalian 
membranes, while TG are commonly stored in the cell cytoplasm [25-26]. A previous study 
has shown how supplementation of RPM results in increased lipid accumulation in bovine 
preimplantation embryos [16]. However, dilapidation via centrifugation can increase the 
cryopreservation of bovine embryos, resulting in viable embryos that can be utilized as 
donors [27].Unfortunately, the extent of research regarding the specific lipid classes 
present in the bovine embryo are limited. In the current study, embryos from cows 
supplemented with RPM showed an increase in TG and PC lipid content with an overall 
increase in polyunsaturated lipids. Ferreira et al. [23] reported similar results regarding an 
increase in PC lipids that contained a high degree of unsaturation for bovine embryos. 
Likewise, evaluation of fatty acid composition of lipids in cattle, sheep, and pig oocytes 
revealed that TG lipids contained the greatest fatty acid rich fraction by mass [17]. A 
possible explanation for the increased TG concentrations in the embryos may be a result of 
the RPM supplementation enabling cows to efficiently export TG from the liver, possibly 
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effecting the TG content of the embryos [11]. Increased embryonic TG content indicates 
that these embryos have excess energy substrates that could be utilized for other 
physiological processes [28]. Additionally, lipid profiles in Bos indicus and Bos Taurus 
suggest contributions towards embryonic development and changes in pre-ovulation [28].  
 Previous studies have demonstrated the importance of lipids in the uterine 
environment as well as influencing embryo implantation to improve fertility [29-30]. 
Lysophosphatidic acid (LPA), a phospholipid derivative, may be an important factor in 
embryo implantation: LPA deficient mice had smaller embryos with decreased 
implantation and lower prostaglandin components in the uterus, all factors that contribute 
to reduced embryo vitality [30]. Despite the difference in species, the increase in PC lipids 
for embryos harvested from cows supplemented with RPM may suggest improvement in 
embryo implantation as compared to cows in control, similar to the mice embryos observed 
by Ye et al. [30]. The metabolism of methionine results in S-adenosylmethionine, which is 
a major methylation agent, leading to methylation of phospholipids into 
phosphatidylcholine, which may explain the increase in PC lipids found in embryos from 
RPM supplemented cows [31-32].  
  Ruminant reproduction requires a substantial amount of energy, as stressed by 
Mattos et al. [33], with the most important sources of energy being derived from the fatty 
acids in lipids. The energy usage by the ruminant reproductive tract occurs mainly through 
providing precursors for steroids, ultimately impacting pregnancy rates [33]. In the 
endometrium, platelet-activation factor rapidly hydrolyzes PC, resulting in the formation 
of DG, which has been shown to serve as signal messengers and activate cellular events 
during implantation [34-35]. For the current study, there was decreased PC lipids 
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throughout all time points with a notable increase in DG lipids in the endometrial tissue at 
30 and 73 DIM. It is possible that the PC lipids were hydrolyzed more efficiently in the 
cows supplemented with RPM, which could lead to increased signaling and improved 
implantation. Protein kinase C has been discovered in gonadal tissue and can aid in 
secretory functions [36]. Diacylglycerol increases protein kinase C enzymatic sensitivity 
16-fold in pig ovarian cytosol, possibly resulting in increased endocrine secretions [36]. 
Likewise, as previously stated, LPA is an important component for embryo implantation 
in mice. Ye et al. [37] models the importance of diacylglycerol for the formation of LPA 
which can also aid in uterine receptivity, oocyte maturation, and angiogenesis of the 
placenta and uterus. Based on these studies, diacylglycerol can be considered an important 
component for all aspects of reproduction. A previous study that fed dairy cows 
monounsaturated fatty acids observed an increase in the number of oocytes collected with 
a greater recovery rate [38]. Finally, Wathes et al. [39] describes how severe negative 
energy balance cows have down regulation of the gene PLA2G10 in the bovine uterus, 
which is involved in lipid accumulation and lipoprotein modification. Therefore, cows 
supplemented with RPM may have increased PLA2G10 through reducing negative energy 
balance, possibly aiding in lipid accumulation and transport to the embryo [40]. 
 Furthermore, Staples et al. [41] demonstrates how long chain polyunsaturated fatty 
acids can have beneficial effects on fertility. Polyunsaturated fatty acids, part of the lipids 
group, can inhibit the uterus from producing prostaglandin F2α, leading to increased 
concentrations of cholesterol, which is a precursor of progesterone, and improve survival 
of the embryo through increased lifespan of the corpus luteum [41]. Therefore, it could be 
speculated that since there was an increase in unsaturated lipid abundance, which includes 
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polyunsaturated lipids, in the endometrium at 30 and 73 DIM, the cows supplemented with 
RPM may have improved embryo survival. Supplementation of RPM to multiparous 
Holstein cows resulted in increased ability to maintain pregnancy and overall embryonic 
size, leading to reduced embryo mortality [42]. The typical voluntary waiting period for 
dairy cows to be bred is between 50 and 60 days after calving [43]. The observed increase 
in unsaturated lipids during this time further confirms the importance of lipids in the bovine 
uterus and embryos in order to produce a viable pregnancy.  
 The current study provides a comprehensive analysis of lipid profiles found in 
uterine endometrial tissue and preimplantation embryos from cows supplemented with 
RPM. Lipid profiling of the preimplantation embryos revealed an increase of TG, mainly 
polyunsaturated, which could be utilized for energy by the developing embryo. Moreover, 
the notable increase in DG and monounsaturated lipids signifies the ability of the uterine 
endometrium in cows supplemented with RPM to assist with signaling, embryo 
implantation, and embryo number. Therefore, providing RPM to Holstein cows during the 
transition period and early lactation altered the lipid profiles of preimplantation embryos 
and the uterine endometrium, possibly leading to improved embryonic development and 
survival.   
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FIGURES AND TABLES
Figure 3.1. Principle component scores for lipid markers in embryos from cows (n = 8) fed rumen-protected 
methionine [MET +; n = 5 (G9, G13, G14, H8, H9)] or not [CON ; n = 3(F8, F13, and F14)].    
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Figure 3.2. Principle component scores for lipid markers in uterine biopsies obtained at 15 (A.), 
30 (B.), and 73 (C.) DIM for method 1 from cows fed rumen-protected methionine [MET +; n = 
11 (d15: 165, 8697, 8706, 8770, 8772; d30: 8697, 8706, 8770, 8772, 8781; d73: 847, 8390, 8550, 
8697, 8706, 8768, 8772, 8781)] or not [CON ; n = 9 (d15: 8237, 8690, 8746, 8718, 28092; d30: 
8237, 8348, 8690, 8718; d73: 8348, 8602, 8690, 8718, 8797)].   
A
. 
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Figure 3.3. Principle component scores for lipid markers in uterine biopsies obtained at 15 (A.), 
30 (B.), and 73 (C - D.) DIM for method 2 from cows fed rumen-protected methionine [MET +; n 
= 11 (d15: 165, 8697, 8706, 8770, 8772; d30: 8697, 8706, 8770, 8772, 8781; d73: 847, 8390, 8550, 
8697, 8706, 8768, 8772, 8781)] or not [CON ; n = 9 (d15: 8237, 8690, 8746, 8718, 28092; d30: 
8237, 8348, 8690, 8718; d73: 8348, 8602, 8690, 8718, 8797)].   
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Figure 3.4. Principle component scores for lipid markers in uterine biopsies obtained at 15 (A.), 
30 (B.), and 73 (C - D.) DIM for method 3 from cows fed rumen-protected methionine [MET +; n 
= 11 (d15: 165, 8697, 8706, 8770, 8772; d30: 8697, 8706, 8770, 8772, 8781; d73: 847, 8390, 8550, 
8697, 8706, 8768, 8772, 8781)] or not [CON ; n = 9 (d15: 8237, 8690, 8746, 8718, 28092; d30: 
8237, 8348, 8690, 8718; d73: 8348, 8602, 8690, 8718, 8797)].   
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Figure 3.5. Principle component scores for lipid markers in uterine biopsies obtained at 15 (A.), 
30 (B.), and 73 (C.) DIM for method 4 from cows fed rumen-protected methionine [MET +; n = 
11 (d15: 165, 8697, 8706, 8770, 8772; d30: 8697, 8706, 8770, 8772, 8781; d73: 847, 8390, 8550, 
8697, 8706, 8768, 8772, 8781)] or not [CON ; n = 9 (d15: 8237, 8690, 8746, 8718, 28092; d30: 
8237, 8348, 8690, 8718; d73: 8348, 8602, 8690, 8718, 8797)].   
B
. 
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Figure 3.6. Principle component scores for lipid markers in uterine biopsies obtained at 15 (A.), 
30 (B.), and 73 (C.) DIM for method 5 from cows fed rumen-protected methionine [MET +; n = 
11 (d15: 165, 8697, 8706, 8770, 8772; d30: 8697, 8706, 8770, 8772, 8781; d73: 847, 8390, 8550, 
8697, 8706, 8768, 8772, 8781)] or not [CON ; n = 9 (d15: 8237, 8690, 8746, 8718, 28092; d30: 
8237, 8348, 8690, 8718; d73: 8348, 8602, 8690, 8718, 8797)].   
C
. 
B
. 
A
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Table 3.1. Discovery phase methods and respective scan modes for individual screening of uterine biopsy 
samples for 15, 30 and 73 DIM. Less than 200 MRMs were used per method due to limited time for data 
collection.   
Method Ion Mode 
Number of 
transitions 
Scan mode used for the discovery step 
1 positive 178 Phosphatidylcholine (PC), Sphyngomyelin (SM), Glycerolipids 
containing palmitoleic acid (16:1), palmitic acid (16:0), DHA (22:6),  
tetracosahexaenoic acid (24:6) and dotriacontanoic acid (32:0). 
2 positive 178 Glycerolipids containing palmitic acid (16:0), linolenic acid (18:3), 
linoleic acid (18:2), oleic acid (18:1), stearic acid (18:0), eicosatetraenoic 
acid (20:4), eicosatrienoic acid (20:3), eicosadienoic acid (20:2), 
arachidic acid (20:0), docosatetraenoic acid (22:4), docosahexaenoic acid 
(22:6). 
3 positive 178 Glycerolipids containing 22:6, 22:4, docosadienoic acid (22:2), 
docosenoic acid (22:1), behenic acid (22:0), lignoceric acid (24:0), 
Phosphatidylcholine (PC) and Sphyngomyelin (SM). 
4 positive 181 Phosphatidylcholine (PC) and Sphyngomyelin (SM), Ceramides, 
Phosphatidylinositol (PI), Acylcarnitines, nervonic acid (24:1), montanic 
acid (28:0). 
5 negative 64 Glycerolipids containing 14:1 residue, 16:0, 18:0, Phosphatidylinositol 
(PI). 
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Table 3.2. Principle components (PC), proportion (p), and 
cumulative proportion (Cp) of the principle component 
analysis for embryos retrieved at 73 DIM.  
PC p Cp 
PC1* 37.9 37.9 
PC2* 19.8 57.6 
PC3* 15.4 73.1 
PC4* 11.9 85.0 
93.2 
97.8 
PC5 8.2 93.2 
PC6 4.6 97.8 
* Extracted principle components.  
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Table 3.3. Tentative attributions for embryo lipid markers retrieved at 73 DIM.  
Detected m/z  Tentative Attribution1, 2 
708.90  [PC(P-30:2)+Na]+* 
710.90  [PC(P-30:1)+Na]+ 
714.80 [PC(O-30:0)+Na]+ 
715.80 [TG(42:4)+H]+; [TG(40:1)+Na]+ 
725.51 [SM(d34:1)+Na]+** 
732.90 [PC(32:1)+H]+  
782.50 [PC(36:4)+H]+; [PC(34:1)+Na]+ 
787.50 [SM(d40:1) +H]+**; [TG(44:1)+K]+ 
827.50 [TG(50:4)+H]+; [TG(48:1)+Na]+ 
872.90 [PC(42:1)+H]+; [PC(P-42:4)+Na]+ 
874.90 [PC(42:0)+H]+; [PC(O-42:4)+Na]+ 
875.90 [TG(54:8)+H]+; [TG(52:5)+Na]+ 
879.50 [TG(54:6)+H]+; [TG(52:3)+Na]+ 
889.80 [TG(54:1)+H]+; [TG(54:12)+Na]+; [TG(52:6)+K]+ 
890.00 [TG(54:1)+H]+; [TG(52:6)+K]+ 
891.80 [TG(54:0)+H]+; [TG(54:11)+Na]+; [TG(52:5)+K]+ 
896.60 [PC(44:3)+H]+; [PC(42:0)+Na]+ 
906.71 non-attributed3 
907.60 [TG(56:6)+H]+; [TG(54:3)+Na]+; [TG(54:11)+K]+ 
1036 [TG(66:12)+H]+; [TG(64:9)+Na]+; [TG(64:17)+K]+; [TG(62:3)+K]+ 
* Tentative attributions based on the detection of m/z 710.9 due to lipid not being listed in the LipidMaps 
database. 
** Sphingenine base. 
1 All lipids were tentatively attributed based on the LipidMaps database considering up to 0.3 Da of difference 
from the theoretical mass except m/z 708.9 and m/z 732.9, which were up to 0.4 Da of difference from the 
theoretical mass. 
2 Abbreviations: PC = phosphatidylcholine; SM = sphingomyelin; TG = triacylglycerol; ‘O-‘ prefix = presence 
of alkyl ether substituent; ‘P-‘ prefix = presence of 1Z-alkenyl ether (Plasmalogen) substituent. 
3 Detected mass does not have attributed lipid according to LipidMaps Database.  
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Table 3.4. Loadings for extracted PCs from embryos retrieved at 73 DIM.  
Lipid Attribution, m/z 
Loadings 
PC1 PC2 PC3 PC4 
[PC(P-30:2)+Na]+, 708.90 -0.02553 0.2094* 0.067397 -0.08207 
[PC(P-30:1)+Na]+, 710.90 0.015795 0.099157 0.19717* -0.01483 
[PC(O-30:0)+Na]+, 714.80 0.03144 0.08519 0.21261* -0.0358 
[TG(42:4)+H]+; [TG(40:1)+Na]+, 715.80 -0.00959 0.050163 0.2305* 0.03359 
[SM(d34:1)+Na]+, 725.51 -0.04028 0.112 0.012998 -0.24116* 
[PC(32:1)+H]+ , 732.90 -0.01979 -0.06936 0.070696 0.26425* 
[PC(36:4)+H]+; [PC(34:1)+Na]+, 782.50 0.00659 0.048021 -0.01326 -0.28234* 
[SM(d40:1) +H]+; [TG(44:1)+K]+, 787.50 0.037169 0.026102 -0.02989 -0.27096* 
[TG(50:4)+H]+; [TG(48:1)+Na]+, 827.50 0.16208* 0.0178 0.040546 0.026245 
[PC(42:1)+H]+; [PC(P-42:4)+Na]+, 872.90 0.062582 -0.20502* -0.04687 0.014932 
[PC(42:0)+H]+; [PC(O-42:4)+Na]+, 874.90 0.050318 -0.21739* -0.01145 -0.01364 
[TG(54:8)+H]+; [TG(52:5)+Na]+, 875.90 0.043132 -0.21933* -0.02285 -0.01805 
[TG(54:6)+H]+; [TG(52:3)+Na]+, 879.50 0.1597* 0.020988 -0.04363 0.058251 
[TG(54:1)+H]+; [TG(54:12)+Na]+; [TG(52:6)+K]+, 889.80 0.021502 0.10304 0.21591* 0.063981 
[TG(54:1)+H]+; [TG(52:6)+K]+, 890.00 -0.04114 -0.06088 -0.01762 0.23844* 
[TG(54:0)+H]+; [TG(54:11)+Na]+; [TG(52:5)+K]+, 891.80 0.089997 -0.0634 0.19442* -0.02529 
[PC(44:3)+H]+; [PC(42:0)+Na]+, 896.60 0.1601* 0.02304 -0.02526 0.013761 
non-attributed, 906.71 0.15459* 0.002509 -0.0815 0.065127 
[TG(56:6)+H]+; [TG(54:3)+Na]+; [TG(54:11)+K]+, 907.60 0.15469* 0.061866 -0.04206 0.046579 
[TG(66:12)+H]+; [TG(64:9)+Na]+; [TG(64:17)+K]+; 
[TG(62:3)+K]+, 1036 
0.043428 -0.20878* -0.02373 -0.02275 
* Loadings used for interpretation of PCA.   
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Table 3.5. Least squares means and associated standard errors of normalized lipid marker intensity ion counts1 
for embryos from Holstein cows supplemented with rumen-protected methionine (MET) or not (CON) from 
21 days before calving until 73 DIM. 
Variable  
Treatment  P-value 
CON2 MET3 SEM4 TRT 
Lipid Attribution, m/z     
[PC(P-30:2)+Na]+, 708.90 2.25 1.79 0.17 0.09 
[SM(d34:1)+Na]+, 725.51 5.44 2.13 1.30 0.11 
[TG(50:4)+H]+; [TG(48:1)+Na]+, 827.50 1.41 2.78 0.37 0.06 
[PC(42:1)+H]+; [PC(P-42:4)+Na]+, 872.90 1.48 2.10 0.16 0.03 
[PC(42:0)+H]+; [PC(O-42:4)+Na]+, 874.90 5.67 8.30 0.78 0.04 
[TG(54:8)+H]+; [TG(52:5)+Na]+, 875.90 2.07 3.01 0.31 0.05 
[TG(54:6)+H]+; [TG(52:3)+Na]+, 879.50 1.56 4.81 1.26 0.11 
non-attributed, 906.70 1.34 2.92 0.63 0.12 
[TG(66:12)+H]+; [TG(64:9)+Na]+; [TG(64:17)+K]+; [TG(62:3)+K]+, 1036 1.29 3.27 0.66 0.07 
Group     
Unsaturated 21.16 24.25 1.98 0.26 
Monounsaturated 8.32 5.05 1.32 0.10 
Polyunsaturated 17.07 25.90 1.42  0.003 
1Intensity ion counts multiplied by 1000.  
2CON = control, no rumen protected methionine, n = 3. 
3MET = rumen protected methionine, n = 5. 
4 SEM multiplied by 1000.  
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Table 3.6. Principle components (PC) of each method, 
proportion (p), and cumulative proportion (Cp) of the 
principle component analysis for uterine biopsies retrieved at 
15 DIM.  
Variable p Cp 
Method 1   
PC1* 93.4 93.4 
PC2 3.3 96.8 
PC3 1.9 98.6 
PC4 0.6 99.2 
Method 2   
PC1* 63.5 63.5 
PC2* 16.1 79.6 
PC3 8.9 88.5 
PC4 4.8 93.3 
Method 3   
PC1* 61.2 61.2 
PC2* 22.6 83.9 
PC3 5.3 89.1 
PC4 4.6 93.8 
Method 4   
PC1* 71.4 71.4 
PC2* 14.0 85.3 
PC3 5.6 91.0 
PC4 5.2 96.2 
Method 5   
PC1* 71.2 71.2 
PC2* 20.7 91.9 
PC3 3.6 95.6 
PC4 1.9 97.5 
* Extracted principle components. 
 
  
92 
 
Table 3.7. Tentative attributions for relevant MRMs (parent -> fragment) for uterine 
biopsy lipid markers retrieved at 15 DIM. 
Method Tentative Attribution1 
Method 1, m/z  
480.7 -> 223.4 PA (20:0) 
481.7 -> 224.4 PC (O-16:0); PE (18:0); LysoPE (18:0);PS (P-16:0/0:0) 
554.8 -> 281.5 LysoPE (24:6); PS (20:0); CER (d34:1) 
556.9 -> 283.6 CER (d18:0/16:0(2OH)) 
582.1 -> 206.8 PS (22:0); CER (36:1) 
628.6 -> 371.3 PE-CER (d32:3) 
631.9 -> 358.6 PA (P-18:0/14:1) 
685.9 -> 428.6 PA (O-36:3); PA (P-36:2); PE-CER (d36:3) 
701.6 -> 428.3 DG (44:4); PA (36:2) 
Method2, m/z  
432.1 -> 134.8 non-attributed 
432.2 -> 106.9 non-attributed 
432.2 -> 110.9 non-attributed 
554 -> 208.7 LysoPE (24:6); PS (20:0); CER (d34:1) 
555 -> 209.7 PG (20:0); CER (d34:1) 
612.7 -> 283.4 PI (P-20:0) 
614 -> 272.7 non-attributed 
627.8 -> 282.5 non-attributed 
628.9 -> 283.6 PE-CER (d32:3) 
684.7 -> 355.4 PE (32:4) 
685.6 -> 356.3 PA (O-36:3); PA (P-36:2); PE-CER (d36:3) 
757.6 -> 428.3 PG (O-36:4); PG (P-36:3); PA (40:2) 
850 -> 550.7 TG (52:7); PG (42:7); PG (O-42:0); PI (O-36:2); PI (P-36:1) 
875.9 -> 576.6 TG (54:7); PG (44:7); PI (P-38:1) 
878 -> 604.7 TG (54:7); PG (44:7); PI (O-38:2); PI (P-38:1) 
Method 3, m/z  
524.6-> 184.2 PC (18:0) 
630.8 -> 281.5 DG (36:0) 
701.7 -> 184.2 SM (d34:2) 
703.6 -> 354.3 SM (d34:1); PC (30:0); DG (42:3); PA (36:1) 
704.7 -> 355.4 PC (30:1) 
705.7 -> 356.4 non-attributed 
732.4 -> 184.2 SM (d36:0); PC (32:1) 
735.6 -> 184.2 PC (32:0) 
746.4 -> 184.2 PC (O-34:1); PC (P-34:0) 
759.7 -> 184.2 SM (d38:1) 
760.7 -> 184.2 PC (34:1) 
761.6 -> 184.2 SM (d38:0) 
770.7 -> 184.2 PC (O-36:3); PC (P-36:2) 
775.4 -> 184.2 PC (P-36:1) 
777.6 -> 428.3 PA (44:6); PC (36:7);   PE (P-40:6) 
777.9 -> 432.6 TG (44:1); PG (36:1); PI (30:3); PA (42:6) 
Method 4, m/z  
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Table 3.7 (cont.)  
410 -> 132.7 non-attributed 
454.2 -> 70.9 PC (12:0); PC (O-14:0); PE (16:0); LysoPE (16:0) 
480.9 -> 282.2 PA (20:0) 
481 -> 282.2 CER (d30:1) 
520.2 -> 282.2 non-attributed 
554.4 -> 266.4 CER (d34:1) 
554.9 -> 282.2 CER (d34:1) 
555.4 -> 282.2 non-attributed 
586.2 -> 88.9 non-attributed 
613.2 -> 282.2 non-attributed 
759.5 -> 282.2 SM (d38:1) 
777.3 -> 282.2 PA (44:6) 
789.7 -> 184.2 PC (36:0); PC (P-38:6) 
808.8 -> 184.2 PC (38:5); PI-CER (d36:1) 
809.7 -> 184.2 PC (38:5); PI-CER (d36:1) 
810.8 -> 184.2 PC (38:4); PI-CER (d36:0) 
Method 5, m/z  
538 -> 283.2 PS (O-20:0) 
539.5 -> 283.2 DG (30:0); PG (20:0) 
540.1 -> 283.2 PC (20:5) 
612.3 -> 283.2 oxidized glutathione 
Abbreviations: CER = Ceramide; DG = Diacylglycerol; PA = Phosphatidic acid;  PC = Phosphatidylcholine; PE = 
Phosphatidyletanolamine; PG = Phosphatidylglycerol; PI = Phosphatidylinositol; PS = Phosphatidylserine; SM = 
Sphingomyelin; TG = Triacylglycerol; ‘O-‘ prefix = presence of alkyl ether substituent; ‘P-‘ prefix = presence of 1Z-
alkenyl ether (Plasmalogen) substituent 
1 Only protonated (positive ion mode) and deprotonated (negative ion mode) molecules were considered. LipidMaps 
database was interrogated for lipids with structure compatible with the scan mode used considering up 0.5 Da of 
difference. If no match was found, other lipids listed at LipidMaps and metabolites listed at Metlin, considering up to 1.0 
Da of difference, were included as tentative attributions. Mixtures of isomeric lipids may occur at the same MRM. Only 
one MRM has been listed for MRMs of similar m/z both for parent and fragment; We consider them to be the same 
lipid(s) due to the low resolution power of the mass spectrometer used. 
 
  
94 
 
Table 3.8. Loadings for extracted PCs from uterine biopsies retrieved at 15 DIM.  
Variable 
Loadings 
PC1 PC2 
Method 1, m/z   
PA (20:0), 480.7 -> 223.4 0.077447* 
 
PC (O-16:0); PE (18:0); LysoPE (18:0);PS (P-16:0/0:0), 481.7 -> 224.4 0.077435* 
LysoPE (24:6); PS (20:0); CER (d34:1), 554.8 -> 281.5 0.077437* 
CER (d18:0/16:0(2OH)), 556.9 -> 283.6 0.07745* 
PS (22:0); CER (36:1), 582.1 -> 206.8 0.077473* 
PE-CER (d32:3), 628.6 -> 371.3 0.077458* 
PA (P-18:0/14:1), 631.9 -> 358.6 0.077464* 
PA (O-36:3); PA (P-36:2); PE-CER (d36:3), 685.9 -> 428.6 0.077463* 
DG (44:4); PA (36:2), 701.6 -> 428.3 0.077452* 
Method 2, m/z   
non-attributed, 432.1 -> 134.8 -0.0032513 0.17827* 
non-attributed, 432.2 -> 106.9 -0.0038316 0.1781* 
non-attributed, 432.2 -> 110.9 -0.01201 0.17326* 
non-attributed, 432.2 -> 134.9 -0.0030881 0.17975* 
non-attributed, 432.3 -> 107.0 -0.013443 0.17435* 
LysoPE (24:6); PS (20:0); CER (d34:1), 554 -> 208.7 -0.094111* -0.0089101 
PG (20:0); CER (d34:1), 555 -> 209.7 -0.094075* -0.010197 
PI (P-20:0), 612.7 -> 283.4 -0.093958* -0.0071977 
non-attributed, 614 -> 272.7 -0.093893* -0.0094803 
non-attributed, 627.8 -> 282.5 -0.093997* -0.010075 
PE-CER (d32:3), 628.9 -> 283.6 -0.094049* -0.011156 
PE (32:4), 684.7 -> 355.4 -0.094032* -0.011176 
PA (O-36:3); PA (P-36:2); PE-CER (d36:3), 685.6 -> 356.3 -0.093927* -0.010199 
PG (O-36:4); PG (P-36:3); PA (40:2), 757.6 -> 428.3 -0.093961* -0.0095323 
TG (52:7); PG (42:7); PG (O-42:0); PI (O-36:2); PI (P-36:1), 850 -> 550.7 0.003314 -0.17921* 
TG (54:7); PG (44:7); PI (P-38:1), 875.9 -> 576.6 0.0034138 -0.17397* 
TG (54:7); PG (44:7); PI (O-38:2); PI (P-38:1), 878 -> 604.7 0.017534 -0.17815* 
Method 3, m/z   
PC (18:0), 524.6 -> 184.2 0.095679* -0.0014537 
DG (36:0), 630.8 -> 281.5 0.095667* -0.0016222 
SM (d34:2), 701.7 -> 184.2 0.095682* -0.0048856 
SM (d34:1); PC (30:0); DG (42:3); PA (36:1), 703.6 -> 354.3 0.095562* -0.00092218 
PC (30:1), 704.7 -> 355.4 0.095599* -0.0013151 
non-attributed, 705.7 -> 356.4 0.095596* -0.0034002 
SM (d36:0); PC (32:1), 732.4 -> 184.2 0.011759 0.14156* 
PC (32:0), 735.6 -> 184.2 0.023448 -0.14761* 
PC (O-34:1); PC (P-34:0), 746.4 -> 184.2 -0.02512 0.14448* 
PC (O-34:1); PC (P-34:0), 746.5 -> 184.2 -0.010005 0.14829* 
SM (d38:1), 759.7 -> 184.2 0.0079709 0.14761* 
PC (34:1), 760.7 -> 184.2 -0.016557 0.15191* 
PC (34:1), 760.8 -> 184.2 0.02745 0.14402* 
SM (d38:0), 761.6 -> 184.2 -0.032017 0.14365* 
PC (O-36:3); PC (P-36:2), 770.7 -> 184.2 0.095683* 0.00056504 
PC (P-36:1), 775.4 -> 184.2 0.023861 0.14256* 
PA (44:6); PC (36:7);  PE (P-40:6), 777.6 -> 428.3 0.095572* -0.00081625 
TG (44:1); PG (36:1); PI (30:3); PA (42:6), 777.9 -> 432.6 0.095559* -0.00067994 
Method 4, m/z   
non-attributed, 410 -> 132.7 0.087916* 0.0042966 
PC (12:0); PC (O-14:0); PE (16:0); LysoPE (16:0), 454.2 -> 70.9 0.087758* 0.00042023 
PA (20:0), 480.9 -> 282.2 0.039353 -0.16734* 
CER (d30:1), 481 -> 282.2 0.041939 -0.1656* 
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Table 3.8 (cont.)   
CER (d30:1), 481.1 -> 282.2 0.032323 -0.17478* 
CER (d30:1), 481.2 -> 282.2 0.038947 -0.1683* 
non-attributed, 520.2 -> 282.2 0.087674* 0.0092541 
CER (d34:1), 554.4 -> 266.4 0.087692* 0.007086 
CER (d34:1), 554.9 -> 282.2 0.050191 -0.15323* 
non-attributed, 555.4 -> 282.2 0.087655* -0.0054699 
non-attributed, 586.2 -> 88.9 0.087572* 0.012301 
non-attributed, 613.2 -> 282.2 0.087608* -0.0012227 
SM (d38:1), 759.5 -> 282.2 0.087559* 0.00823 
PA (44:6), 777.3 -> 282.2 0.087589* 0.0030725 
PC (36:0); PC (P-38:6), 789.7 -> 184.2 0.019234 0.15073* 
PC (38:5); PI-CER (d36:1), 808.8 -> 184.2 0.043995 -0.15222* 
PC (38:5); PI-CER (d36:1), 809.7 -> 184.2 -0.045353 -0.15243* 
PC (38:4); PI-CER (d36:0), 810.8 -> 184.2 -0.038387 -0.15385* 
Method 5, m/z   
PS (O-20:0), 538 -> 283.2 0.14611* 0.039607 
DG (30:0); PG (20:0), 539.3 -> 283.2 0.016622 -0.27105* 
DG (30:0); PG (20:0), 539.4 -> 283.2 0.014594 -0.27063* 
DG (30:0); PG (20:0), 539.5 -> 283.2 0.012635 -0.27031* 
PC (20:5), 540.1 -> 283.2 0.14703* -0.028184 
oxidized glutathione, 612.3 -> 283.2 0.14552* 0.047996 
* Loadings used for interpretation of PCA.   
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Table 3.9. Least squares means and associated standard errors of normalized lipid marker intensity 
ion counts1 for uterine endometrial biopsies obtained at 15 DIM from Holstein cows supplemented 
with rumen-protected methionine (MET) or not (CON) 21 days before calving until 73 DIM. 
 Treatment  P-value 
Variable  CON2 MET3 SEM4 TRT 
Method 3, m/z  
PC (O-34:1); PC (P-34:0), 746.4 -> 184.2 6.05 4.89 0.52 0.15 
PC (O-34:1); PC (P-34:0), 746.5 -> 184.2 4.46 3.61 0.35 0.13 
PC (34:1), 760.7 -> 184.2 2.66 2.13 0.23 0.14 
Group     
Saturated 10.51 8.50 0.86 0.14 
Unsaturated/ Monounsaturated 13.16 10.62 1.07 0.13 
1Intensity ion counts multiplied by 1000.  
2CON = control, no rumen protected methionine, n = 5. 
3MET = rumen protected methionine, n = 5. 
4SEM multiplied by 1000.  
* Variables for Methods 1, 2, 4, and 5 were not statistically different.  
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Table 3.10. Principle components (PC) of each method, 
proportion (p), and cumulative proportion (Cp) of the 
principle component analysis for uterine biopsies retrieved at 
30 DIM.  
PC p Cp 
Method 1  
PC1* 81.2 81.2 
PC2* 16.3 97.5 
PC3 1.3 98.8 
PC4 0.7 99.5 
Method 2   
PC1* 66.5 66.5 
PC2* 25.7 92.2 
PC3 4.0 96.2 
PC4 2.3 98.5 
Method 3   
PC1* 71.8 71.8 
PC2* 13.7 85.5 
PC3 7.0 92.4 
PC4 3.0 95.4 
Method 4   
PC1* 50.8 50.8 
PC2* 34.6 85.4 
PC3 6.8 92.2 
PC4 2.5 94.8 
Method 5   
PC1* 71.4 71.4 
PC2* 14.4 85.8 
PC3 4.6 90.4 
PC4 3.9 94.3 
* Extracted principle components. 
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Table 3.11. Tentative attributions for relevant MRMs (parent -> fragment) for uterine 
biopsy lipid markers retrieved at 30 DIM. 
Method Tentative Attribution1 
Method 1, m/z  
481 -> 207.7 PA (20:0) 
481.9 -> 224.6 PC (O-16:0); PE (18:0); LysoPE (18:0); PS (P-16:0/0:0) 
553.8 -> 280.5 β-Cryptoxanthin 
554.1 -> 280.8 LysoPE (24:6); PS (20:0); CER (d34:1) 
555.9 -> 282.6 non-attributed 
582.1 -> 206.8 PS (22:0); CER (36:1) 
611.7 -> 354.4 DG (36:7) 
612 -> 354.7 PI (P-20:0) 
627.9 -> 354.6 non-attributed 
627.9 -> 370.6 non-attributed 
629.8 -> 356.5 PE-CER (d32:3) 
630 -> 356.7 non-attributed 
686 -> 428.7 PE (32:3); PA (O-36:3); PA (P-36:2); PE-CER (d36:3); GlcCER (d32:2) 
701.9 -> 428.6 DG (44:4); PA (36:2) 
702.8 -> 429.5 PC (30:2); PE (P-34:1); PS (30:3) 
703.8 -> 430.5 DG (42:3); PA (36:1) 
787.8 -> 184.2 SM (d40:1); PC (36:2) 
Method 2, m/z  
432.2 -> 106.9 non-attributed 
432.2 -> 110.9 non-attributed 
555 -> 209.7 PG (20:0); CER (d34:1) 
609.8-> 280.5 DG (36:8) 
611.5 -> 270.2 DG (36:7); PG (24:0) 
611.9 -> 282.6 DG (36:7); PG (24:0) 
613 -> 283.7 DG (36:6); PA (30:4) 
613.9 -> 272.6 DG (36:6); PA (30:4) 
614 -> 272.7 non-attributed 
628.9 -> 283.6 non-attributed 
683.8 -> 354.5 PI (20:0) 
684.2 -> 354.9 PE (32:4) 
686.7 -> 345.4 PE (32:3); PA (O-36:3); PA (P-36:2); PE-CER (d36:3); GlcCER (d32:2) 
700.8 -> 359.5 PC (30:3);  PE (O-34:3);  PE (P-34:2); PS (30:4); GlcCER (d34:1) 
850 -> 550.7 TG (52:7); PG (42:7); PI (O-36:2);  PI (P-36:1) 
863.8 -> 590.5 TG (52:0); PG (42:0); PI (36:2) 
Method 3, m/z  
487.9-> 132.6 Calyxinin and ceanin (sphingoid bases) 
705.7 -> 356.4 PA (P-38:6) 
706.4 -> 184.2 PC (O-38:4); PC (P-38:3) 
718.3 -> 184.2 PC (O-32:1); PC (P-32:0) 
720.4 -> 184.2 PC (O-32:1); PC (P-32:0) 
734 -> 184.2 SM (d36:0) 
735.5 -> 184.2 PC (32:0) 
759.5 -> 184.2 SM (d38:1) 
763.8 -> 184.2 PC (P-36:5) 
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Table 3.11 (cont.)  
766.3 -> 184.2 PC (O-36:5); PC (P-36:4) 
776.8 -> 431.5 PC (36:7); PE (P-40:6) 
777.6 -> 428.3 TG (44:1); PG (36:1); PI (30:3); PA (42:6) 
777.6 -> 432.3 TG (44:1); PG (36:1); PI (30:3); PA (42:6) 
785.5 -> 184.2 SM (d40:2) 
851.7 -> 502.4 TG (52:6); PG (42:6) 
Method 4, m/z  
352.7 -> 85.1 
15(R),19(R)-hydroxy PGF2α; 9,11-methane-epoxy PGF1α; δ-12-PGD2; 
Dodecylphosphocholine 
388.7 -> 85.1 17-phenyl trinor PGF2α amide; 17-phenyl trinor PGF2α 
410.8 -> 85.1 PA (16:0); LPA (16:0) 
447.1 -> 225.2 17-phenoxy trinor Prostaglandin F2α isopropyl ester 
475.8 -> 85.1 PE (18:3); LysoPE (18:3) 
538.3 -> 282.2 CER (d34:1) 
539.2 -> 282.2 non-attributed 
540.2 -> 282.2 CER (d34:0) 
583.4 -> 282.2 non-attributed 
611.3 -> 282.2 DG (36:7); PG (24:0) 
613.2 -> 282.2 Non-attributed 
630.7 -> 445.5 Non-attributed 
803.7 -> 184.2 non-attributed 
811.4 -> 184.2 SM (d42:2) 
816.8 -> 184.2 PC (38:1) 
Method 5, m/z  
407.8 -> 222.6 non-attributed 
464.9 -> 283.2 PA (20:0) 
538 -> 283.2 
PC (18:0); PC (O-20:0); PE (22:0); LysoPE (22:0); PS (P-20:0); CER 
(d34:1) 
666.5 -> 369.1 GlcCER (d32:3) 
804.9 -> 241.3 non-attributed 
807.4 -> 241.3 PI (32:1) 
Abbreviations: CER = Ceramide; DG = Diacylglycerol; PA = Phosphatidic acid;  PC = Phosphatidylcholine; PE = 
Phosphatidyletanolamine; PG = Phosphatidylglycerol; PI = Phosphatidylinositol; PS = Phosphatidylserine; SM = 
Sphingomyelin; TG = Triacylglycerol; ‘O-‘ prefix = presence of alkyl ether substituent; ‘P-‘ prefix = presence of 1Z-
alkenyl ether (Plasmalogen) substituent 
1 Only protonated (positive ion mode) and deprotonated (negative ion mode) molecules were considered. LipidMaps 
database was interrogated for lipids with structure compatible with the scan mode used considering up 0.5 Da of difference. 
If no match was found, other lipids listed at LipidMaps and metabolites listed at Metlin, considering up to 1.0 Da of 
difference, were included as tentative attributions. Mixtures of isomeric lipids may occur at the same MRM. Only one 
MRM has been listed for MRMs of similar m/z both for parent and fragment; We consider them to be the same lipid(s) due 
to the low-resolution power of the mass spectrometer used. 
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Table 3.12. Loadings for extracted PCs from uterine biopsies retrieved at 30 DIM.  
Variable 
Loadings 
PC1 PC2 
Method 1, m/z   
PA (20:0), 481 -> 207.7 0.082897* -0.0009931 
PC (O-16:0); PE (18:0); LysoPE (18:0); PS (P-16:0/0:0), 481.9 -> 224.6 0.082703* -0.0098268 
β-Cryptoxanthin , 553.8 -> 280.5 0.082637* 0.0099154 
LysoPE (24:6); PS (20:0); CER (d34:1), 554.1 -> 280.8 0.035122 0.16695* 
non-attributed, 555.9 -> 282.6 0.082707* -0.014755 
PS (22:0); CER (36:1), 582.1 -> 206.8 0.0829* -0.010839 
DG (36:7), 611.7 -> 354.4 0.082782* 0.012056 
PI (P-20:0), 612 -> 354.7 0.035631 0.16615* 
non-attributed, 627.9 -> 354.6 0.036366 0.16645* 
non-attributed, 627.9 -> 370.6 0.044434 0.15433* 
non-attributed, 628 -> 354.7 0.022654 0.17736* 
PE-CER (d32:3), 629.8 -> 356.5 0.082788* 0.0074563 
non-attributed, 630 -> 356.7 0.041854 0.15901* 
PE (32:3); PA (O-36:3); PA (P-36:2); PE-CER (d36:3); GlcCER (d32:2), 686 -> 
428.7 
0.035952 0.16239* 
DG (44:4); PA (36:2), 701.9 -> 428.6 0.041176 0.15628* 
PC (30:2); PE (P-34:1); PS (30:3), 702.8 -> 429.5 0.082916* 0.01049 
DG (42:3); PA (36:1), 703.8 -> 430.5 0.082641* -0.010796 
SM (d40:1); PC (36:2), 787.8 -> 184.2 0.028642 -0.15724* 
Method 2, m/z   
non-attributed, 432.1 -> 106.8 0.00060549 -0.14692* 
non-attributed, 432.2 -> 106.9 -0.0083653 -0.14648* 
non-attributed, 432.2 -> 110.9 -0.0018655 -0.14491* 
non-attributed, 432.3 -> 107.0 -0.0080815 -0.14561* 
PG (20:0); CER (d34:1), 555 -> 209.7 0.092405* 0.0012313 
DG (36:8), 609.8 -> 280.5 -0.013692 0.14623* 
DG (36:7); PG (24:0), 611.5 -> 270.2 0.092401* 0.0043867 
DG (36:7); PG (24:0), 611.9 -> 282.6 0.00011163 0.14761* 
DG (36:6); PA (30:4), 613 -> 283.7 0.015945 0.14579* 
DG (36:6); PA (30:4), 613.9 -> 272.6 0.092422* 0.0014103 
non-attributed, 614 -> 272.7 0.092384* -0.0022228 
non-attributed, 628.9 -> 283.6 0.092401* -0.00091948 
PI (20:0), 683.8 -> 354.5 -0.014515 0.14449* 
PE (32:4), 684.2 -> 354.9 -0.0036464 0.1452* 
PE (32:3); PA (O-36:3); PA (P-36:2); PE-CER (d36:3); GlcCER (d32:2), 686.7 -> 
345.4 
0.092384* -0.002556 
PC (30:3); PE (O-34:3);  PE (P-34:2); PS (30:4); GlcCER (d34:1), 700.8 -> 359.5 0.092396* 0.0037452 
TG (52:7); PG (42:7); PI (O-36:2); PI (P-36:1), 850 -> 550.7 0.092387* 0.0051479 
TG (52:0); PG (42:0); PI (36:2), 863.8 -> 590.5 0.092404* 0.003079 
Method 3, m/z   
Calyxinin and ceanin (sphingoid bases), 487.9 -> 132.6 0.088451* -0.0031426 
PA (P-38:6), 705.7 -> 356.4 0.08844* -0.0018079 
PC (O-38:4); PC (P-38:3), 706.4 -> 184.2 -0.0069848 -0.15648* 
PC (O-32:1); PC (P-32:0), 718.3 -> 184.2 0.01453 0.16665* 
PC (O-32:1); PC (P-32:0), 720.4 -> 184.2 0.019719 -0.1695* 
SM (d36:0), 734 -> 184.2 0.01575 -0.17068* 
PC (32:0), 735.5 -> 184.2 -0.0005473 -0.17322* 
SM (d38:1), 759.5 -> 184.2 -0.034816 -0.15775* 
PC (P-36:5), 763.8 -> 184.2 0.088444* 0.00061941 
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Table 3.12 (cont.)   
PC (O-36:5); PC (P-36:4), 766.3 -> 184.2 -0.0127 0.16252* 
PC (O-36:5); PC (P-36:4), 766.5 -> 184.2 0.0015162 0.16928* 
PC (36:7); PE (P-40:6), 776.8 -> 431.5 0.088451* -0.002177 
TG (44:1); PG (36:1); PI (30:3); PA (42:6), 777.6 -> 428.3 0.088444* -0.0018177 
TG (44:1); PG (36:1); PI (30:3); PA (42:6), 777.6 -> 432.3 0.088449* -0.0019971 
TG (44:1); PG (36:1); PI (30:3); PA (42:6), 777.8 -> 432.5 0.08845* -0.0021894 
TG (44:1); PG (36:1); PI (30:3); PA (42:6), 777.9 -> 432.6 0.088449* -0.002119 
SM (d40:2), 785.5 -> 184.2 -0.015131 -0.17927* 
TG (52:6); PG (42:6), 851.7 -> 502.4 0.08845* -0.0021656 
Method 4, m/z   
15(R),19(R)-hydroxy PGF2α; 9,11-methane-epoxy PGF1α; δ-12-PGD2; 
Dodecylphosphocholine, 352.7 -> 85.1 
0.0083536 -0.12266* 
17-phenyl trinor PGF2α amide; 17-phenyl trinor PGF2α, 388.7 -> 85.1 -0.0070143 -0.12144* 
PA (16:0); LPA (16:0), 410.8 -> 85.1 -0.0091036 -0.12231* 
17-phenoxy trinor Prostaglandin F2α isopropyl ester, 447.1 -> 225.2 0.0061826 -0.12179* 
PE (18:3); LysoPE (18:3), 475.8 -> 85.1 0.0082725 -0.12239* 
CER (d34:1), 538.3 -> 282.2 0.1006* 0.012009 
CER (d34:1), 538.9 -> 282.2 0.10216* 0.0087594 
CER (d34:1), 539 -> 282.2 0.098898* 0.02466 
non-attributed, 539.2 -> 282.2 0.10336* 0.0059062 
CER (d34:0), 540.2 -> 282.2 0.10106* -0.019341 
non-attributed, 583.4 -> 282.2 0.01206 -0.12273* 
DG (36:7); PG (24:0), 611.3 -> 282.2 0.10203* -0.019823 
Non-attributed, 613.2 -> 282.2 0.099578* -0.032682 
Non-attributed, 630.7 -> 445.5 -0.0053216 -0.1219* 
Non-attributed, 803.7 -> 184.2 -0.01031 -0.12371* 
SM (d42:2), 811.4 -> 184.2 -0.099954* 0.002497 
SM (d42:2), 811.5 -> 184.2 -0.099742* -0.0059411 
PC (38:1), 816.8 -> 184.2 -0.0080715 -0.12363* 
Method 5, m/z   
non-attributed, 407.8 -> 222.6 0.14766* 0.011728 
PA (20:0), 464.9 -> 283.2 -0.051037 0.26192* 
PC (18:0); PC (O-20:0); PE (22:0); LysoPE (22:0); PS (P-20:0); CER (d34:1), 538 
-> 283.2 
0.14766* 0.006588 
GlcCER (d32:3), 666.5 -> 369.1 0.14776* -1.49E-05 
non-attributed, 804.9 -> 241.3 0.012835 -0.27869* 
PI (32:1), 807.4 -> 241.3 0.063051 0.26296* 
* Loadings used for interpretation of PCA.   
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Table 3.13. Least squares means and associated standard errors of normalized lipid marker 
intensity ion counts1 for uterine endometrial biopsies obtained at 30 DIM from Holstein cows 
supplemented with rumen-protected methionine (MET) or not (CON) 21 days before calving 
until 73 DIM. 
 Treatment  P-value 
Lipid, m/z  CON2 MET3 SEM4 TRT 
Method 1, m/z     
LysoPE (24:6); PS (20:0); CER (d34:1), 554.1 -> 280.8 4.65 10.77 2.70 0.14 
DG (36:7), 611.7 -> 354.4 0.59 1.49 0.42 0.15 
PI (P-20:0), 612 -> 354.7 1.41 19.81 7.86 0.12 
non-attributed, 627.9 -> 354.6 4.08 10.14 2.38 0.10 
non-attributed, 627.9 -> 370.6 1.87 3.95 0.94 0.14 
non-attributed, 630 -> 356.7 2.58 5.66 1.22 0.10 
DG (44:4); PA (36:2), 701.9 -> 428.6 1.82 3.76 0.88 0.14 
Method 2, m/z     
non-attributed, 432.1 -> 106.8 14.35 8.85 2.07 0.09 
non-attributed, 432.2 -> 110.9 16.44 10.48 2.65 0.14 
DG (36:8), 609.8 -> 280.5 2.00 7.76 2.13 0.08 
DG (36:7); PG (24:0), 611.9 -> 282.6 2.29 6.73 1.70 0.09 
DG (36:6); PA (30:4), 613 -> 283.7 1.99 3.85 0.70 0.09 
Method 4, m/z     
CER (d34:1), 538.3 -> 282.2 2.83 6.67 0.97 0.02 
CER (d34:1), 538.9 -> 282.2 2.30 8.99 1.87 0.03 
CER (d34:1), 539 -> 282.2 2.82 12.77 2.14 0.01 
non-attributed, 539.2 -> 282.2 2.69 12.26 2.78 0.04 
CER (d34:0), 540.2 -> 282.2 1.14 2.90 0.58 0.06 
SM (d42:2), 811.4 -> 184.2 26.18 16.55 3.78 0.10 
SM (d42:2), 811.5 -> 184.2 17.54 10.93 2.43 0.08 
Group     
Saturated 9.48 40.21 12.19 0.10 
Unsaturated 64.99 90.26 7.82 0.05 
Monounsaturated 12.59 39.20 6.51 0.02 
Polyunsaturated 57.05 61.83 6.65 0.61 
1Intensity ion counts multiplied by 1000.  
2CON = control, no rumen protected methionine, n = 4. 
3MET = rumen protected methionine, n = 5. 
4SEM multiplied by 1000.  
* Variables for Methods 3 and 5 were not statistically different. 
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Table 3.14. Principle components (PC) of each method, 
proportion (p), and cumulative proportion (Cp) of the 
principle component analysis for uterine biopsies retrieved at 
73 DIM.  
Method p Cp 
Method 1   
PC1* 89.7 89.7 
PC2 5.4 95.0 
PC3 2.4 97.4 
PC4 1.2 98.6 
Method 2   
PC1* 55.5 55.5 
PC2* 16.6 72.1 
PC3* 11.3 83.4 
PC4 7.1 90.5 
Method 3   
PC1* 55.9 55.9 
PC2* 14.7 70.6 
PC3* 11.9 82.6 
PC4 7.1 89.6 
Method 4   
PC1* 65.2 65.2 
PC2* 16.8 82.0 
PC3 6.4 88.5 
PC4 5.4 93.9 
Method 5   
PC1* 67.6 67.6 
PC2* 16.3 83.9 
PC3 4.3 88.2 
PC4 2.7 90.8 
* Extracted principle components.  
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Table 3.15. Tentative attributions for relevant MRMs (parent -> fragment) for uterine 
biopsy lipid markers retrieved at 73 DIM. 
Method Tentative Attribution1 
Method 1, m/z  
535.8 -> 264.5 DG (30:3) 
536.9 -> 265.6 PC (18:1); PE (22:1); LysoPE (22:1) 
551.9 -> 280.6 DG (P-32:1); PS (20:1) 
609.8 -> 338.5 DG (36:8) 
611.6 -> 354.3 DG (36:7) 
613.7 -> 356.4 DG (36:6); PA (30:4) 
628.7 -> 371.4 PE-CER (d32:3) 
701.5 -> 428.2 DG (42:4); PA (36:2) 
Method 2, m/z  
535.9 -> 206.6 DG (30:3); PC (18:1); PE (22:1); LysoPE (22:1) 
536.1 -> 206.8 PC (P-20:0); PE (22:1); LysoPE (22:1) 
537 -> 207.7 DG (30:2); PG (20:2); PA (24:2) 
555.9 -> 210.6 PG (20:0) 
609.8 -> 280.5 DG (36:8) 
611 -> 282.2 DG (36:7); PG (24:0) 
611.8 -> 270.5 DG (36:7); PG (24:0) 
612.7 -> 271.4 PI (P-20:0) 
612.7 -> 283.4 PI (P-20:0) 
613.9 -> 272.6 DG (36:6); PA (30:4) 
629.9 -> 284.6 PE-CER (d32:3) 
685.9 -> 344.6 PA (O-36:3); PA (P-36:2); PE-CER (d36:3) 
686.7 -> 345.4 PE (32:3); PA (O-36:3); PA (P-36:2); PE-CER (d36:3); GlcCER (d32:2) 
848.1 -> 548.8 TG (52:8); PS (P-42:6); PG (O-42:1) 
850 -> 550.7 TG (52:7); PG (42:7); PG (O-42:0); PI (O-36:2); PI (P-36:1) 
850 -> 576.7 TG (52:7); PG (42:7); PI (O-36:2); PI (P-36:1) 
875.7 -> 576.4 TG (54:8); PG (44:8); PI (O-38:3); PI (P-38:2) 
876 -> 602.7 TG (54:8); PG (44:8); PI (O-38:3); PI (P-38:2) 
876.9 -> 577.6 PS (42:0) 
878 -> 578.7 TG (54:7); PG (44:7); PI (O-38:2); PI (P-38:1) 
878 -> 604.7 TG (54:7); PG (44:7); PI (O-38:2); PI (P-38:1) 
905.9 -> 606.6 TG (56:7); PI (40:9); PI (O-40:2); PI (P-40:1) 
Method 3, m/z  
410 -> 56.7 
PGF2α diethyl amide; Tafluprost (free acid); 1-Palmitoyl 
Lysophosphatidic Acid; N-arachidonoyl taurine 
438.3 -> 89 PC (O-12:1); PE (P-16:0) 
444 -> 58.7 non-attributed 
524.6 -> 184.2 PC (18:0) 
701.7 -> 184.2 SM (d34:2) 
703.5 -> 184.2 SM (d34:1); PC (30:0) 
704.5 -> 184.2 PC (30:1) 
720.8 -> 184.2 PC (O-32:1); PC (P-32:0) 
732.8 -> 184.2 SM (d36:0); PC (32:1) 
758.2 -> 184.2 PC (34:2) 
759.5 -> 184.2 SM (d38:1) 
761.6 -> 184.2 SM (d38:0) 
784.6 -> 184.2 PC (36:3) 
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Table 3.15 (cont.)  
785.6 -> 184.2 SM (d40:2) 
786.1 -> 184.2 PC (36:2) 
Method 4, m/z  
293.8 -> 97.1 non-attributed 
454.2 -> 70.9 PC (12:0); PC (O-14:0); PE (16:0); LysoPE (16:0) 
475.8 -> 85.1 PE (18:3); LysoPE (18:3) 
520.2 -> 282.2 non-attributed 
537.2 -> 282.2 non-attributed 
548.4 -> 107.1 PC (O-20:2); PC (20:2); PS (20:3) 
556.4 -> 282.2 CER (d34:0); CER (t34:0) 
610.5 -> 266.4 CER (d38:1) 
611.3 -> 282.2 DG (36:7); PG (24:0) 
613.3 -> 282.2 DG (36:6); PA (30:4) 
808.7 -> 184.2 PC (38:5); PI-CER (d36:1) 
811.7 -> 184.2 SM (d42:3) 
812.8 -> 184.2 PC (38:3) 
814.9 -> 184.2 PC (38:2); PI-CER (t34:0) 
815.5 -> 184.2 SM (d42:1) 
816.5 -> 184.2 PC (38:1) 
Method 5, m/z  
537.7 -> 283.2 DG (30:2); PG (20:2); PA (24:0) 
538.3 -> 283.2 
PC (18:0); PC (O-20:0); PE (22:0); LysoPE (22:0); PS (P-20:0); CER 
(d34:1) 
539.3 -> 283.2 DG (30:1); PG (20:1) 
630.2 -> 283.2 DG (36:0) 
Abbreviations: CER = Ceramide; DG = Diacylglycerol;  PA = Phosphatidic acid;  PC = Phosphatidylcholine; PE = 
Phosphatidyletanolamine; PG = Phosphatidylglycerol; PI = Phosphatidylinositol; PS = Phosphatidylserine; SM = 
Sphingomyelin; TG = Triacylglycerol; ‘O-‘ prefix = presence of alkyl ether substituent; ‘P-‘ prefix = presence of 1Z-
alkenyl ether (Plasmalogen) substituent 
1 Only protonated (positive ion mode) and deprotonated (negative ion mode) molecules were considered. LipidMaps 
database was interrogated for lipids with structure compatible with the scan mode used considering up 0.5 Da of difference. 
If no match was found, other lipids listed at LipidMaps and metabolites listed at Metlin, considering up to 1.0 Da of 
difference, were included as tentative attributions. Mixtures of isomeric lipids may occur at the same MRM. Only one 
MRM has been listed for MRMs of similar m/z both for parent and fragment; We consider them to be the same lipid(s) due 
to the low-resolution power of the mass spectrometer used. 
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Table 3.16. Loadings for extracted PCs from uterine biopsies retrieved at 73 DIM.  
Variable 
Loadings 
PC1 PC2 PC3 
Method 1, m/z  
DG (30:3), 535.8 -> 264.5 0.079008*   
PC (18:1); PE (22:1); LysoPE (22:1), 536.8 -> 265.5 0.078867*   
PC (18:1); PE (22:1); LysoPE (22:1), 536.9 -> 265.6 0.07897*   
DG (P-32:1); PS (20:1), 551.9 -> 280.6 0.079029*   
DG (36:8), 609.8 -> 338.5 0.078917*   
DG (36:7), 611.6 -> 354.3 0.078975*   
DG (36:6); PA (30:4), 613.7 -> 356.4 0.079037*   
PE-CER (d32:3), 628.7 -> 371.4 0.078854*   
DG (42:4); PA (36:2), 701.5 -> 428.2 0.078868*   
Method 2, m/z    
DG (30:3); PC (18:1); PE (22:1); LysoPE (22:1), 535.9 -> 206.6 -0.00073173 -0.037724 -0.21689* 
PC (P-20:0); PE (22:1); LysoPE (22:1), 536 -> 206.7 -0.0078914 -0.032463 -0.21843* 
PC (P-20:0); PE (22:1); LysoPE (22:1), 536.1 -> 206.8 -0.018699 -0.032858 -0.21379* 
DG (30:2); PG (20:2); PA (24:2), 537 -> 207.7 0.0017452 -0.017404 -0.21904* 
PG (20:0), 555.9 -> 210.6 0.10091* -0.0019663 -0.00081302 
DG (36:8), 609.8 -> 280.5 0.0062614 -0.028247 -0.21441* 
DG (36:7); PG (24:0), 611 -> 282.2 -0.017493 -0.022301 -0.21204* 
DG (36:7); PG (24:0), 611.8 -> 270.5 0.10085* -0.00073998 8.89E-05 
DG (36:7); PG (24:0), 611.9-> 282.6 -0.0012196 -0.0051756 -0.21466* 
DG (36:7); PG (24:0), 612 -> 283.2 -0.013136 -0.014976 -0.21497* 
DG (36:7); PG (24:0), 612.1 -> 283.2 -0.0098319 -0.025115 -0.21443* 
PI (P-20:0), 612.7 -> 271.4 0.10085* -0.0033852 0.0011715 
PI (P-20:0), 612.7 -> 283.4 0.10086* 0.0011438 -0.0077951 
DG (36:6); PA (30:4), 613.9 -> 272.6 0.10085* -0.0035307 0.00099438 
PE-CER (d32:3), 629.9 -> 284.6 0.10086* -0.0030597 0.0018155 
PA (O-36:3); PA (P-36:2); PE-CER (d36:3), 685.5 -> 344.2 0.10086* -0.0036149 0.0011988 
PA (O-36:3); PA (P-36:2); PE-CER (d36:3), 685.9 -> 344.6 0.10087* -0.0036207 0.0014069 
PE (32:3); PA (O-36:3); PA (P-36:2); PE-CER (d36:3); GlcCER 
(d32:2), 686.7 -> 345.4 
0.10088* -0.0024669 0.001662 
TG (52:8); PS (P-42:6); PG (O-42:1), 848.1 -> 548.8 -0.014584 -0.17482* 0.04843 
TG (52:7); PG (42:7); PG (O-42:0); PI (O-36:2); PI (P-36:1), 850 -> 
550.7 
0.021081 -0.17147* 0.055649 
TG (52:7); PG (42:7); PI (O-36:2); PI (P-36:1), 850 -> 576.7 -0.0032157 -0.17146* 0.066973 
TG (54:8); PG (44:8); PI (O-38:3); PI (P-38:2), 875.7 -> 576.4 -0.028648 -0.1695* 0.047555 
TG (54:8); PG (44:8); PI (O-38:3); PI (P-38:2), 876 -> 602.7 -0.026825 -0.17042* 0.049595 
PS (42:0), 876.9 -> 577.6 -0.025555 -0.17089* 0.049965 
TG (54:7); PG (44:7); PI (O-38:2); PI (P-38:1), 878 -> 578.7 -0.0056087 -0.17612* 0.05326 
TG (54:7); PG (44:7); PI (O-38:2); PI (P-38:1), 878 -> 604.7 -0.0030891 -0.17645* 0.055231 
TG (56:7); PI (40:9); PI (O-40:2); PI (P-40:1), 905.9 -> 606.6 0.006346 -0.17556* 0.051311 
Method 3, m/z    
PGF2α diethyl amide; Tafluprost (free acid); 1-Palmitoyl 
Lysophosphatidic Acid; N-arachidonoyl taurine , 410 -> 56.7 
0.099298* 0.0037846 0.021807 
PC (O-12:1); PE (P-16:0), 438.3 -> 89 0.099267* 0.0073764 0.018282 
non-attributed , 444 -> 58.7 0.099199* 0.001393 0.010901 
PC (18:0), 524.6 -> 184.2 0.099307* 0.0083504 0.016691 
SM (d34:2), 701.7 -> 184.2 0.099571* 0.0025467 0.0090799 
SM (d34:1); PC (30:0), 703.4 -> 184.2 0.049977 -0.065749 -0.1663* 
SM (d34:1); PC (30:0), 703.5 -> 184.2 0.040862 -0.064301 -0.17525* 
PC (30:1), 703.6 -> 184.2 0.049119 -0.071082 -0.16354* 
PC (30:1), 704.2 -> 184.2 0.051796 -0.040138 -0.16812* 
PC (30:1), 704.3 -> 184.2 0.055261 -0.050444 -0.164* 
PC (30:1), 704.4 -> 184.2 0.052472 -0.053217 -0.16976* 
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Table 3.16 (cont.)    
PC (30:1), 704.5 -> 184.2 0.042814 -0.068976 -0.17108* 
PC (30:1), 704.8 -> 184.2 0.099476* 0.013658 0.0019777 
PC (30:1), 705.8 -> 356.5 0.099032* 0.007176 0.023821 
PC (O-32:1); PC (P-32:0), 720.8 -> 184.2 0.099131* 0.0093951 0.02269 
SM (d36:0); PC (32:1), 732.8 -> 184.2 0.099363* -0.0014104 0.022943 
PC (34:2), 758.2 -> 184.2 -0.052211 0.14595* -0.039223 
PC (34:2), 759 -> 184.2 0.051649 0.14773* -0.010776 
SM (d38:1), 759.3 -> 184.2 -0.023085 0.16918* -0.032798 
SM (d38:1), 759.4 -> 184.2 -0.031947 0.16334* -0.057741 
SM (d38:1),759.5 -> 184.2 0.010104 0.16848* -0.047386 
SM (d38:1), 759.7 -> 184.2 0.0443 -0.063377 0.16389* 
SM (d38:0), 761.6 -> 184.2 -0.019074 -0.093572 0.16823* 
SM (d40:2), 784.6 -> 184.2 -0.037025 0.15154* -0.010411 
SM (d40:2), 785.6 -> 184.2 0.025631 0.15866* -0.079867 
SM (d40:2), 785.9 -> 184.2 -0.0079489 0.1546* -0.045612 
PC (36:2), 786.1 -> 184.2 -0.046916 0.14726* -0.04031 
Method 4, m/z    
non-attributed , 293.8 -> 97.1 0.090291* -0.030321  
PC (12:0); PC (O-14:0); PE (16:0); LysoPE (16:0), 454.2 -> 70.9 0.090392* -0.030747  
PE (18:3); LysoPE (18:3), 475.8 -> 85.1 0.090057* -0.034958  
non-attributed, 520.2 -> 282.2 0.090593* -0.02619  
non-attributed, 537 -> 282.2 0.060834 0.13412*  
non-attributed, 537.1 -> 282.2 0.061291 0.13268*  
non-attributed, 537.2 -> 282.2 0.061811 0.13231*  
PC (O-20:2); PC (20:2); PS (20:3), 548.4 -> 107.1 0.090094* -0.020433  
CER (d34:0); CER (t34:0), 556.4 -> 282.2 0.09037* -0.031571  
CER (d38:1), 610.5 -> 266.4 0.090087* -0.033096  
DG (36:7); PG (24:0), 611.3 -> 282.2 0.090302* 0.013903  
DG (36:6); PA (30:4), 613.3 -> 282.2 0.09067* -0.017939  
PC (38:5); PI-CER (d36:1), 808.7 -> 184.2 0.031298 -0.13301*  
SM (d42:3), 811.7 -> 184.2 -0.03205 -0.13933*  
PC (38:3), 812.8 -> 184.2 -0.0079363 -0.14964*  
PC (38:2); PI-CER (t34:0), 814.9 -> 184.2 0.018974 -0.14197*  
SM (d42:1), 815.5 -> 184.2 -0.025513 -0.13406*  
PC (38:1), 816.5 -> 184.2 -0.021776 -0.13853*  
Method 5, m/z    
DG (30:2); PG (20:2); PA (24:0), 537.7 -> 283.2 0.14999* 0.020438  
PC (18:0); PC (O-20:0); PE (22:0); LysoPE (22:0); PS (P-20:0); CER 
(d34:1), 538.3 -> 283.2 
0.15058* -0.003351  
DG (30:1); PG (20:1), 539.2 -> 283.2 0.010094 -0.30029*  
DG (30:1); PG (20:1), 539.3 -> 283.2 -0.0099179 -0.30281*  
DG (30:1); PG (20:1), 539.4 -> 283.2 -0.011485 -0.30404*  
DG (36:0), 630.2 -> 283.2 0.15011* 0.040817  
* Loadings used for interpretation of PCA.   
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Table 3.17. Least squares means and associated standard errors of normalized lipid marker intensity 
ion counts1 for uterine endometrial biopsies obtained at 73 DIM from Holstein cows supplemented with 
rumen-protected methionine (MET) or not (CON) 21 days before calving until 73 DIM. 
 Treatment  P-value 
Variable   CON2 MET3 SEM4 TRT 
Method 2, m/z  
DG (30:3); PC (18:1); PE (22:1); LysoPE (22:1), 535.9 -> 206.6 2.75 4.82 0.61 0.02 
DG (30:3); PC (18:1); PE (22:1); LysoPE (22:1), 536 -> 206.7 4.51 10.72 1.93 0.03 
PC (P-20:0); PE (22:1); LysoPE (22:1), 536.1 -> 206.8 7.00 19.76 3.75 0.02 
DG (30:2); PG (20:2); PA (24:2), 537 -> 207.7 2.26 3.61 0.47 0.04 
DG (36:8), 609.8 -> 280.5 2.24 3.56 0.45 0.04 
DG (36:7); PG (24:0), 611 -> 282.2 4.42 10.49 2.75 0.11 
DG (36:7); PG (24:0), 611.9 -> 282.6 2.23 3.12 0.45 0.15 
DG (36:7); PG (24:0), 612 -> 283.2 2.95 4.76 0.87 0.13 
DG (36:7); PG (24:0), 612.1 -> 283.2 3.66 7.23 1.65 0.12 
Method 3, m/z     
PC (34:2), 758.2 -> 184.2 23.77 19.96 1.80 0.12 
Method 4, m/z     
non-attributed, 537 -> 282.2 18.23 57.55 11.49 0.02 
non-attributed, 537.1 -> 282.2 19.73 63.16 12.15 0.02 
non-attributed, 537.2 -> 282.2 17.44 55.78 10.82 0.02 
PC (38:5); PI-CER (d36:1), 808.7 -> 184.2 1.33 1.18 0.08 0.14 
SM (d42:3), 811.7 -> 184.2 2.77 2.16 0.21 0.05 
PC (38:3), 812.8 -> 184.2 2.07 1.78 0.11 0.06 
PC (38:1), 816.5 -> 184.2 8.79 7.40 0.71 0.15 
Group     
Saturated 20.25 45.36 9.37 0.06 
Unsaturated 70.74 100.50 12.95 0.10 
Monounsaturated 24.38 43.88 5.89 0.02 
Polyunsaturated  50.54 62.89 7.02 0.19 
1Intensity ion counts multiplied by 1000.  
2CON = control, no rumen protected methionine, n = 5. 
3MET = rumen protected methionine, n = 8. 
4SEM multiplied by 1000.  
* Variables for Methods 1 and 5 were not statistically different. 
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CHAPTER 4 
SUMMARY AND CONCLUSIONS 
 The overall objective of this thesis was to evaluate the effects of rumen-protected 
methionine on the reproductive status of the dairy cow during the transition from parturition to 
lactation and to identify lipid profiles of the preimplantation embryo and endometrial tissue. We 
have concluded that supplementation of rumen-protected methionine to Holstein cows during the 
transition period can improve uterine function through increased glandular morphology and 
neutrophil infiltration. Likewise, supplementation of rumen-protected methionine effects lipid 
profiling of the preimplantation embryo and endometrial tissue in a way that may benefit 
embryonic development and vitality. The current research study demonstrates how simple 
nutritional implementations may be applied to dairy farms in order to improve reproductive 
success.  
 Furthermore, the observation of neutrophil extracellular trap formation in the bovine 
endometrial tissue may spark further interest regarding how neutrophils act in the uterine 
environment and how this may impact reproductive efficiency. As previously stated, an increase 
in neutrophil number in the uterus has been used as a diagnosis for uterine infection in the past. 
Conversely, we have shown beginning evidence that the increase in neutrophil infiltration may be 
an indicator of a robust immune response rather than a diagnosis for postpartal uterine infections. 
Further research in needed to increase the understanding of the neutrophil in the uterine 
environment of dairy cows, especially in regards to neutrophil extracellular trap formation.  
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APPENDIX A 
A SIMPLE TECHNIQUE TO DETECT METRITIS 
 
 It is no secret that giving birth is a stressful situation for both the cow and her reproductive 
tract. As a result, the cow’s immune system becomes compromised, which can result in infection 
from the birthing process. Metritis is the infection and inflammation of the uterus that is common 
in many high producing dairy cows. This uterine disease can be caused by a difficult birth, retained 
fetal membranes, which is also known as retained placenta, nutritional deficiencies, and unsanitary 
calving environments. Metritis can result in decreased fertility and milk production as well as 
increased calving intervals and farm culling rate, which can lead to detrimental economic losses 
for any dairy farm. These economical costs can range from $100-$300 per metritis case which 
includes the cost of medication, increased calving intervals, milk withholding, and losses due to 
culling. A recent survey in 2006 revealed that the average US dairy farm has about 120 cows.  
Since metritis has a 20% prevalence rate in lactating dairy cows, this means that 24 of the total 
120 cows will have metritis after calving. Treating all 24 of these cases would result in an 
economical loss of $7,200 per year. By detecting and preventing metritis in the early stages, the 
economical and reproductive losses can be minimized.  
 Metritis is characterized as the presence of abnormal vaginal discharge that is typically 
yellow or brownish-red with a very strong odor as seen in Figure A.1. Depending on the severity 
of the infection, metritis can also be associated with other systemic symptoms such as lethargic 
behavior and fever (> 39.50C).  
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In many cases, a hard and inflamed uterus can palpated. Majority of metritis cases occur 
within the first 14 days after calving with a peak frequency around 5 to 7 days after birth which 
can be seen in Figure A.2.  Although it is not common, metritis can also occur 21 days after calving. 
Once metritis is diagnosed, the cow 
should also be examined for other 
metabolic and infectious diseases, such 
as ketosis and displaced abomasum, as 
these diseases are commonly associated 
with metritis.  
The “gold standard” diagnostic method for uterine inflammation is made on the basis of 
cytology. However, this is not a simple procedure and not practical to be done at the farm level.  
Conversely, examination of the vaginal contents for the presence of pus can be performed via 
manual examination of the vagina and withdrawal of the mucus for inspection.  
Observing vaginal secretions in free-stall beds is one way of examining vaginal content. 
However, this method of diagnosis for metritis has shown to be ineffective. In a recent study 
 Figure A.2                                                                    Galvao et al. 
2011 
Figure A. 1. Examples of vaginal discharge from cows with metritis.  
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published in the Journal of Dairy Science, scientist evaluated the effectiveness of using a gloved 
hand versus using the metricheck® device when diagnosing metritis. The gloved hand method is 
fairly similar to the procedure of the metricheck. A gloved hand is simply inserted into the vagina 
of the cow and the contents are slowly removed and evaluated. The study revealed that the 
prevalence of metritis was 47.5% and 36.8% for metricheck and gloved hand, respectively. The 
metricheck device was able to diagnose cows with metritis more efficiently when compared with 
the gloved hand technique.  
The metricheck® device is a very practical and economically effective way to evaluate 
vaginal discharge (Figure A.3). The metricheck® device consists of a stainless steel rod with a 
rubber hemisphere that is used to retrieve the vaginal contents. 
The metricheck device is cleaned with a disinfectant, inserted 
into the vagina of the cow, and then removed while pulling the 
device out at an upward 45 degree angle (Figure A.4). After the 
vaginal content in collected, it can be scored according to the 
quality and smell of the mucus, as seen below (Figure A.5).  
 
 
  
 
 
 
 
 
Figure A.3 
Figure A.4. Withdrawal of Metricheck
®
 Device at an upward 45o 
angle. 
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Using this score system, the mucus can described as:  
 Score 0 = clear or translucent mucus; 
 Score 1 = mucus containing flecks of white or off-white pus; 
 Score 2 = discharge containing ≤50% white or off-white mucopurulent 
material; 
 Score 3 = discharge containing ≥50% purulent material, usually white or 
sanguineous. 
 The smell is classified as not having smell (score 0) or a strong odorous smell (score 3). 
These scores reflect the presence and the amount of bacteria in the uterus, vaginal discharge with 
a smell score of 0 means that there is a low number of pathogenic bacteria in the uterine 
environment and vaginal discharge with a score of 3 with a strong smell means that there is 
presence of bacterial infection in the uterus. Since 95% of metritis cases occur within the first 14 
days postpartum, utilizing the metricheck® device during this time is optimal for detecting metritis. 
This process is very easy to preform, does not require intense training, and is a comfortable and 
sanitary experience for the cow as compared to the gloved hand method. The metricheck® device 
Figure A.5. Vaginal discharge scoring for metricheck.                          Sheldon et al. 2005        
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is a useful and practical tool to assess mucus of the cranial vagina as an indicator for metritis. The 
following link provides a step by step video of how to use the metricheck device: 
http://dairyfocus.illinois.edu/sites/dairyfocus.illinois.edu/files/Vol3Issue1.pdf. 
 Most common treatments for metritis are either using intrauterine antibiotics or systemic 
antibiotics. Systemic antibiotics are widely approved for the use in dairy cows as compared to 
intrauterine antibiotics. Common systemic antibiotics are ceftiofur hydrochloride, ceftiofur 
sodium, and ceftiofur crystalline free acid. Crystalline free acids tend to be the antibiotic of choice 
because it has long lasting effects. However, consultation with the farm veterinarian is always 
recommended before administering medication. Treatment for metritis is warranted when the cow 
has a combined metricheck score and smell score that is above 3. Therefore, the cow would have 
a vaginal discharge score that is more than half purulent material and the discharge would have a 
bad odor.  
 Our group at the University of Illinois Urbana-Champaign Dairy Farm is evaluating the 
uterine environment of dairy cows from parturition to early lactation. We are evaluating vaginal 
discharge through using the metricheck® device. From the current data received, 69.7% of the 
cows on this trial had metritis between 4 to 17 days in milk post calving. Figure 6 shows the 
percentages of cows with metritis between 4 to 30 days in milk post calving while specifically 
looking at metricheck + smell score, smell score, and metricheck score.  
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The graphs above follow a similar distribution with the majority of metritis cases ranging 
from 4 to 17 days in milk. Figure A.7 displays the average scores for metricheck, smell, and 
metricheck + smell in relation to the days in milk. Metritis was characterized in this study by a 
metricheck score average above 2, a smell score average above 1, or a combined metricheck and 
smell score average above 3. These graphs show that cows with a higher metricheck score and a 
high smell score were most prevalent during the 4 to 17 days in milk range.  
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Figure A.6. Percentage of cows with metritis for metricheck + smell score > 3, smell score = 3, and 
metricheck score > 2.  
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Figure A.7. Average Scores for metricheck, smell, and metricheck + smell.  Cows were 
classified as having metritis if the metricheck smell + score or metricheck score were > 2 or a 
smell score > 1.   
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Diagnosing metritis at an early stage is beneficial for both the cow and the farm itself. The 
metricheck® device allows for accurate diagnosis of metritis so that the cow can be treated as early 
as possible to avoid further detrimental effects to the cow’s reproductive tract and on the overall 
milk production.  
 
 
